Resident Abstracts

105th Annual Meeting of the American Radium Society. Maui, Hi, May 17-21. 2023

• Koerner, SA, Schad MD, Elgohari B, Richman AH, Vargo JA. Patterns of Failure in Pelvic Node-positive Vulvar Carcinoma: What Is the Correct Dose and Volume for Definitive Radiotherapy? Mini oral presentation
• Abdelhakiem MK, Elgohari B, Mohammed M, Ferris R, Ohr J, Zandberg D, Skinner H, Clump DA. Institutional experience of re-irradiation with stereotactic body radiation therapy for recurrent or secondary primary head and neck cancer. Poster presentation

ACRO, Radiation Oncology Summit, Lake Buena Vista, FL, March 15-18, 2023

• Abdelhakiem MK, Keller A, Bajpai RR, Smith RP, Beriwal S, Benoit R. Cs-131 Prostate Brachytherapy Boost and Effect of SpaceOAR on Patient-Reported Rectal Bleeding. Poster presentation
• Elgohari B, Ellsworth SE. The Effect of Liver Volume Variation on Stereotactic Body Radiation Therapy (SBRT) Planning and Delivery for Upper Abdominal Malignancies. Poster presentation

ESMO Gynaecological Cancers Congress, Barcelona, Spain February 23-24, 2023

• Koerner SA, Schad MD, Elgohari B, Richman AH, Vargo JA. Clinical outcomes for pelvic node-positive vulvar carcinoma in the PET and IMRT era: reassessing the Stage IVb designation. Mini oral presentation

Society for Neuro-Oncology, Tampa Bay, Fl, November 16-20, 2022

• Gersey Z, Mallela A, Zhang X, Pease M, Abdelhakiem, M, Pearce T, Lieberman F, Mantica M, Phillips Rm Bagley S, Nasrallah M, Binder Z, Brem S, Chen I, O'Rourke DM, Zinn P, Siddiqui Z, Amankulor N. Molecular profile consensus clustering defines clinically distinct groups in IDH wild-type glioblastoma

Society of Gynecologic Oncologists (SGO) Whistler, British Columbia, Feb. 2-4, 2023

• Pifer PM, Jaishankar S, Bhargava R, Keller A, Cohen M, Sukumvanich P, Madelein Courtney-Brooks M, Boisen M, Berger JL, Taylor S, Olawaiye A, Lesnock J, Edwards R, Beriwal S, Vargoa JA. Is mismatch repair status prognostic of clinical outcomes in patients with early stage endometrioid endometrial cancer? Poster

65th Annual ASTRO Meeting, October 2022 San Antonio, TX

• Elgohari B, Abdelhakiem M, Lesnock J, Sukumvanich P, Courtney-Brooks M, Boisen M, Berger J, Taylor S, Mahdi H, Olawaiye A, Edwards R, Beriwal S, Vargo JA. Can Adjuvant Chemoradiotherapy Replace Inguinal Lymph Node Dissection after a Positive Sentinel Lymph Node Biopsy in Vulvar Cancer? Poster
• Pifer PM, Hefner A, Molkentine D, Dhawan A, Yang L, Pickering C, Bao R, Ferris R, Patel R, Luke J, Skinner H. In Vivo screening of immunotherapy resistant head and neck squamous cell carcinoma identifies B7-H3 inhibition as a potential radiosensitizer. Quick Pitch Oral (#1041-QP 07 – Bio3 – Radionuclides, Immunotherapy, and Immune Response).
• Koerner SA, Wang H, Olson AC. Tumor control probability modeling and systematic review of oligometastaticprostate cancer treated with stereotactic ablative radiotherapy
• Mulherkar R, Keller A, Houser C, Kim H, Vargo JA, Barry P, Beriwal S. Outcomes of 3D MRI based HDR Brachytherapy with Hybrid Multichannel Vaginal Cylinder Applicator and Freehand Needles for Treatment of Vaginal Disease. Poster
• Musunuru HB, Keller A, Lin S, Mohan R, Ellsworth S. Modeling Potential Lymphocyte-Sparing Effect of Involved-Field Radiotherapy in Rectal Cancer. Poster
• Musunuru HB, Lynch C, Katipally R, Nasser N, Olson A, Chmura S, Gan G, Luke J, Redler G. Developing a CBCT-Guided Online Adaptive Radiotherapy Approach for Isotoxic Delivery of Ultra-High Dose to Oligometastatic Disease in Combination with Immunotherapy. Poster
• Abdelhakiem M, Keller A, Elgohari B, Burton S, Wilhite T, Clump DA. Planning tumor volume and local control following stereotactic body radiation therapy of early-stage NSCLC. Poster

68th Annual Radiation Research Society, October 2022, Big Island, HI

• Epperly MW, Espinal A, Hamade DF, Shields D, Fisher R, Hou W, Wang H, Mukherjee A, Yu J, Van Pijkeren JP, Greenberger JS. Oral administration of Lactobacillus reuteri releasing Interleukin-22(LR-IL-22) ameliorates radiation induced loss of endothelial and Lgr5+GFP+ epithelial stem cells. Poster
• Abdelhakiem, M, Keller A, Elgohari B, Burton S, Wilhite T, Clump D. Institutional outcomes of stereotactic body radiation therapy for early-stage non-small cell lung cancer and associated planning factors.
• Hefner A, Molkentine D, Dhawan A, Yang L, Pifer P, Molkentine J, Abdelhakiem M, Bahri R, Basu S, Pickering C, Myers J, Skinner H. Ezh2 is a potential target for therapy in head and neck cancer.

ABS, June 17-19, 2022, Denver CO

• Keller A, Bajpai RR, Abdelhakiem M, Benoit R, Beriwal S. Smith RP. Effect of Space OAR on Patient-Reported Rectal Bleeding Following External Beam Radiation Therapy and CS-131 Prostate Brachytherapy Boost. Snap oral (E-Poster)

ESTRO, May 6-10, 2022. Copenhagen, Denmark

• Pifer PM, Jaishankar S, Bhargava R, Keller A, Musunuru HB, Cohen M, Sukumvanich P, Courtney-Brooks M, Boisen M, Berger JL, Taylor S, Olawaiye A, Lesnock J, Edwards R, Vargo JA, Beriwal S. Is substantial LVSI prognostic in patients with pathological lymph node-negative endometrial cancer? Poster

Society of Gynecologic Oncologists (SGO) March 18-21, 2022, Phoenix, AZ

• Ertel M, Richman A, Beriwal S, Vargo JA, Lesnock J. Surgical Margins after Neoadjuvant Chemoradiotherapy for Locally Advanced Vulvar Carcinoma: What is an Adequate Margin? Poster

ICHNO-ECHNO 2022 (International Congress on Innovative Approaches in Head and Neck Oncology (ICHNO) and the European Congress on Head and Neck Oncology (ECHNO)) March 3-5, 2022 Brussels Belgium and online

• Koerner SA, Keller A, Clump DA. Does systemic therapy impact failure patterns in locally advanced laryngeal/hypopharyngeal cancer? Poster
• Keller A, Koerner SA, Clump DA. Long-term outcomes of salivary gland malignancies treated with adjuvant radiation therapy. Poster

Radiosurgery Society (RSS) Annual meeting March, 2022 Carlsbad, CA

• Pifer PM, Clump DA, Ferris RL, Duvvuri U, Kim S, Johnson JT, Snyderman CL,Branstetter BF, Zandberg DP, Burton SA, Holeva K, Wang H, Heron DE, Vargo JA. A Prospective, Randomized Phase II Study of Surgery with or without Adjuvant Stereotactic Body Radiotherapy (SBRT) in Patients with Previously-Irradiated Head and Neck Cancer. Poster
• Abdelhakiem MK, Rodriguez-Lopez JL, Patel AK, Lalonde R, Foust E, Clump DA. Stereotactic Body Radiation Therapy on a Flattening-Filter-Free Beam Linear Accelerator: Early Clinical Experience Poster

Multidisciplinary Head & Neck Symposium, February 24-26, 2022 Phoenix, AZ

• Abdelhakiem MK, Bao R, Ferris3 RL, Heymach J, Pickering C, Luke JJ, Skinner HD. Predicted Th2 infiltrate is associated with outcome in HPV(-) head and neck cancer. Plenary Oral Presentation
• Pifer PM, Kumar M, Yang L, Xie T, Frederick M, Hefner A, Beadle B, Dhawan A, Molkentine D, Molkentine J, Myers J, Pickering C, Heymach J, Skinner H. Focal Adhesion Kinase drives resistance to therapy in HPV-negative head and neck squamous cell carcinoma in a p53-dependent manner. Plenary Oral Presentation

64th Annual ASTRO Meeting, October 2021 Chicago, Il

• Musunuru HB, Keller A, Celebrezze J, Beriwal S. Wait and Watch Approach for Patients with Rectal Cancer following Neoadjuvant Therapy. Poster
• Keller A, Kim H, Beriwal S, Smith K, Vargo JA. Cost-Effectiveness of Prophylactic Cranial Irradiation versus MRI Surveillance for Extensive Stage Small Cell Lung Cancer. Poster
• Abdelhakiem M., Olson A, Gill B, Wang H, Davies B, Holeva K, D'Ambrosio D, Wegner R, Heron DE. Patient and Dosimetric Predictors of Genitourinary and Gastrointestinal Toxicity after
  Prostate SBRT: A Secondary Analysis of a Prospective, Multi-institutional Phase II Trial Poster
• Koerner S, Baig T, Kim H, Rodriguez-Lopez JL, Keller A, Beriwal S. Can we avoid Ureters as organs at risk with MRI-based brachytherapy for cervical cancer? A dosimetric feasibility study. Poster
• Richman AH, Patel A, Berwal S, Wilhite T, Burton S, Christie N, Dhupar R, Schuchert M, Clump D. Primary tumor control in stereotactic ablative radiation therapy for large (≥ 5cm) non-small cell lung cancer: Does it last? Poster
• Pifer P, Kumar M, Yang L, Xie T, Frederick M, Molkentine D, Molkentine J, Myers J, Pickering C, Skinner H. Focal Adhesion Kinase drives resistance to therapy in HPV-negative head and neck squamous cell carcinoma in a p53-dependent manner Oral Presentation, Basic/Translational Science Abstract Award
• Donovan E, Albuquerque K, Mantz C, Beriwal S, Keller A, Chen H, Lo S, Leung E. The role of Stereotactic body radiotherapy (SBRT) in oligometastatic and oligoprogressive gynecologic malignancies: A multi-institutional pooled analysis Quick oral pitch
• Lalonde R, Keller A, Huq S. Dosimetric Parameters Related to Local Control and Rate of Distant Metastases in NSCLC SBRT Patients. Poster
• Hamade DF, Epperly M, Fisher R, Hou W, Greenberger JS. Second Generation Probiotic Lactobacillus Reuteri Producing IL-22 (LR-IL-22) Protects the Intestine to Facilitate Whole Abdoment Irradiation (WAI) in Ovarian Cancer. Poster

67th Annual Radiation Research Society, October 2021 online

• Abdelhakiem M, Yang L, Kumar M, Molkentine J, Molkentine D, Hefner A, Luke J, Bao R, Skinner H. Inhibition of PD-1/PD-L1 enhances response to radiation of head and neck tumors through altered CD8+ T-cell function. Poster

American Radium Society, 103 Annual Meeting, September 29-October 2, 2021,online

• Pifer PM, Jaishankar S, Bhargava R, Keller A, Musunuru HB, Patel AK, Sukumvanich P, Courtney-Brooks M, Boisen M, Berger J, Taylor S, Olawaiye A, Lesnock J, Edwards R, Vargo JA, Beriwal S. Is Substantial Lymphovascular Space Invasion Prognostic for Clinical Outcomes in Type II Endometrial Cancer?) Oral Presentation
• Koerner S Rodriguez-Lopez JL, Siddiqui, Flickinger JC. Treatment Fractionation and Lymphopenia in Patients Receiving Radiation for Glioblastoma: Could Hypofractionation Reduce Toxicity? Poster – Best Poster Award
• Keller A, Patel AK, Appleman LJ, Friedland DM, Thomas RA, Olson AC. Outcomes of Axumin PET/CT-detected Prostate Cancer Nodal Recurrences: A Single Institution Experience. Poster
• Ghanta S, Keller A, Rodriguez-Lopez JL, Patel A, Beriwal S. Utility of Prophylactic Cranial Irradiation for Limited Stage Small Cell Lung Cancer in the Modern Era with Magnetic Resonance Imaging Surveillance. Oral presentation
• Rodriguez-Lopez JL, Weiss KR, McGough RL, Gimbel ML, Burton S, Lee SL, John I, Olson AC. High-dose Rate Brachytherapy combined with vacuum-assisted closure for soft tissue sarcomas: A single institution experience. Poster
• Richman AH, Schad MD, Diego EJ, McAuliffe PF, Johnson RR, Steiman J, Kennan DM, Lee JS, Vargo JA, Beriwal S. Dosimetric and Acute Toxicity Analysis with Hypofractionated Regional Nodal Irradiation for Breast Cancer.

ABS, June 2021, Online:

• Keller A, Mulherkar R, Abdelhakiem M, Ghanta S, Benoit R, Smith RP, Beriwal S. Effect of Short-Term Corticosteroid Usage on Acute Urinary Toxicity Following Cs-131 Prostate Brachytherapy, Snap Oral Presentation
• Koerner SA, Benoit R, Houser C, Beriwal S, Smith RP. Patient Reported Urinary Symptoms after Prostate Brachytherapy – Is There a Relationship with Bladder Neck Dose? Snap Oral presentation
• Mulherkar R, Keller A, Houser CJ, Kim H, Vargo JA, Beriwal S. Institutional Experience of 3D MRI based HDR Brachytherapy with hybrid Multichannel Vaginal Cylinder Applicator and Freehand Needles for Treatment of Vaginal Disease. Oral Presentation

ROECSG, May 2021, Online

• Keller A, Richman AH, Musunuru HB, Kim H, Vargo JA, Beriwal S. Methodology and efficacy of weekly web-based Radiation Oncology Educational Conference. Recorded oral

World Congress of Brachytherapy, May 2021, Online

• Rodriguez-Lopez JL, Ling DC, Keller A, Kim H, Mojica-Marquez AE; Glaser SM; Beriwal S. Does dose to the ureter predict for ureteral stenosis? – Analysis of 3D MRI-based brachytherapy. Oral

ASCO Genitourinary Cancers Symposium February, 2021

• Schad MD, Rodriguez-Lopez JL, Patel A, Houser CJ, Horne ZD, Benoit RM, Smith RP, Beriwal S. Intraprostatic calcification and biochemical recurrence in men treated with Cs-131 prostate brachytherapy. Poster presentation

63rd Annual ASTRO Meeting, Miami, Fld

• Musunuru HB, Patel A, Rodriguez-Lopez JL, Brufsky A, Beriwal S. Impact of Metastasis Directed Therapy on Progression and Survival in MetachronousOligometastatic Breast cancer: An Extended Follow-up Study. Poster
• Keller A, Rodriguez-Lopez JL, Beriwal S. Utilization of prophylactic cranial irradiation for extensive stage small cell lung cancer – is there a benefit in the MRI screening era? Poster presentation
• Iheagwara UK, Quinn A, Johnson B, Vargo JA, Burton A. Endobronchial HDR Brachytherapy for Post-Transplant or Wegener's Granulomatosis Associated Bronchial Stenosis Poster presentation
• Rodriguez-Lopez JL, Patel AK, Beriwal S, Benoit R, Smith RP. Report of a Large Cohort of Intermediate-Risk Prostate Cancer Patients Treated with Cs-131 Brachytherapy. Poster presentation
• Richman AH, Patel AK, Rodriguez-Lopez JL, Vargo JA, Kim H, Sukumvanich P, Berger J, Boisen MM, Edwards R, Taylor SE, Courtney-Brooks MB, Olawaiye A, Orr B, Lesnock JL, Beriwal S. Do Air Gaps with Image-Guided Vaginal Cuff Brachytherapy Impact Failure Rates in High Intermediate Risk FIGO Stage I Endometrial Cancer Patients? Poster Presentation
• Pifer PM, Bhargava R, Patel AK, Ling DC, Orr B, Sukumvanich P, Courtney-Brooks M, Boisen M, Berger J, Taylor SE, Olawaiye A, Comerci J, Lesnock J, Edwards R, Vargo JA, Beriwal S. Is the Risk of Substantial LVSI in Stage I Endometrial Cancer Similar to PORTEC in the North American Population? – A Single Institution Study. Oral presentation
• Schad MD, Patel AK, Ling DC, Smith RP, and Beriwal S. Adoption of and Adherence to Institutional Dosimetric Guidelines for Hypofractionated Prostate Radiation Therapy in an Integrated Radiation Oncology Network. Digital Poster
• Hathout L, Wang Y, Elshaikh M, Dimitrova I, Damast S, Li J, Fields E, Beriwal S, Keller A, Kidd E, Usoz M, Jolly S, Jaworski E, Leung E, Donovan E, Taunk N, Russo A, Lea J, Albuquerque K, Lee L. Does sequencing of adjuvant therapy influence outcome for stage IIIC endometrial carcinoma? A multi-institutional analysis.Oral presentation
• Lee S, Mahler P, Olson S, Witt J, Musunuru HB, Bassetti M, Yadav P. Comparison of Cardiac Substructure Dosimetry in Gastro-Esophageal Junction Cancer: Respiratory-Gated MR-Linac Plans Versus 4DCT VMAT Plans. Poster
• Abdelhakiem M, Molkentine D, Molkentine J, Myers J, Ferris R, Pickering C, Skinner H. Mutations in CASP8 and the histone acetyltransferases CREBBP and EP300 are associated with treatment failure in head and neck squamous cell carcinoma. Oral presentation
• Smith RP, Rodriguez-Lopez JL, Patel AK, Benoit RM, Beriwal S. How does the number of positive biopsy cores affect prognosis in patients with intermediate risk prostate cancer treated with Cs-131 prostate brachytherapy? Poster

ESTRO July 31- August 4, Vienna, Austria

• Musunuru H, Mackenzy R, Orr B, Beriwal S. Do we need adjuvant brachytherapy for stage IA high grade endometrial cancer? Oral presentation

American Head and Neck Society Conference, Chicago, Ill, postponed to July 22-25, 2021

• Kaffenberger TM, Patel AK, Lyu L, Wasserman-Wincko T, Clump DA, Heron DE, Johnson JT, Nilsen ML. Quality of life outcomes following radiation and surgery in high stage oropharyngeal cancer. Oral presentation

American Radium Society, Scottsdale, AZ, May 16-19, 2020

• Rodriguez-Lopez JL,Mojica-Marquez AE, Patel AK, Ling DC, Rajagopalan MS, Beriwal S. External Validation of Life Expectancy Prognostic Models in Patients Evaluated for Palliative Radiotherapy at the End of Life. Oral presentation
• Ling DC, Vargo JA, Grimm RJ, Gebhardt BJ, Clump DA, Ferris RL, Ohr JP, Heron DE. Dose-Response Model for Severe Late Laryngeal Toxicity after Stereotactic Body

American Association for Cancer Research (AACR), San Diego April 24-29, 2020

• Rodriguez-Lopez JL, Patel AK, Lalonde R, Foust E, Clump DA. Stereotactic body radiation therapy on the Halcyon^TM: Early clinical experience. Poster presentation.

World Congress of Brachytherapy, Vienna Au, April 2-4, 2020

• Rodriguez-Lopez JL, Mojica-Marquez AE, Ling DC, Kim H, Patel AK, Houser CJ, Beriwal S."Does Dose to the Ureter Predict for Ureteral Stenosis? – Analysis of 3D MRI-Based Brachytherapy" Poster Presentation – GEC-ESTRO Best Junior Presentation
• Keller A, Kim H, Houser CJ, Rodriguez-Lopez JL, Patel AK, Sukumvanich P, Berger JL, Boisen MB, Edwards R, Taylor SE, Courtney-Brooks MB, Olawaiye A, Orr BC, Beriwal S. Feasibility and Outcomes for Cervical Cancer Patients Treated with Hybrid Brachytherapy Applicators. Poster
• Beriwal S, Schad MD, Patel AK, Glaser SM, Balasubramani GK, Showalter TN, Vargo JA. Declining brachytherapy utilization for cervical cancer patients – Have we reversed the trend? Oral Presentation

Radiosurgery Society, Washington, DC, April 2-4, 2020

• Patel AK, Rodriguez-Lopez JL, Burton SA, Flickinger JC, Clump DA. Linear Accelerator Stereotactic Radiosurgery for Treatment of Glomus Jugulare Tumors: Long-Term Follow-up of 39 patients. Poster

ACRO Annual Meeting Fort Lauderdale, FL Feb 26-29, 2020

• Patel AK, Houser C, Benoit R, Smith RP, Beriwal S. Acute Patient-Reported Rectal Bleeding with the Combination of Prostate External Beam Radiation, Brachytherapy Boost, andSpaceOAR^®. Poster
• Musunuru HB, Patel AK, Rodriguez-Lopez JL,Beriwal S. Local Therapy Influences Patterns of Disease Progression in Stage IV Synchronous Oligometastatic Breast Cancer. Poster
• Rodriguez-Lopez JL, Mojica-Marquez AE, Patel AK, Ling DC, Rajagopalan MS, Beriwal S. Physician-Predicted Prognosis and Utilization of Palliative Radiation Therapy at the End-of-Life- An Audit of a Large Cancer Center Network Poster Discussion – Featured during poster walk
• Musunuru HB, Patel AK, Beriwal S. Does Metastases Directed Therapy Improve Outcomes in Synchronous Oligo Metastatic Breast Cancer Patients? A Single Institution Analysis? Poster
• Keller A, Orr B, Ling D, Sukumvanich P, Berger J, Boisen M, Edwards R, Taylor S, Courtney-Brooks M, Olawaiye A, Beriwal S. Outcomes of Patients with Stage IIIC Endometrial Cancer Treated with Adjuvant Sequential Chemotherapy followed by Marrow-Sparing IMRT- A Single Institution Experience. Poster

ASCO Gastrointestinal Symposium San Francisco, CA Jan 23-25, 2020

• Patel AK, Rodriguez-Lopez JL, Bahary N, Zureikat AH, Burton SA, Heron DE, Olson AC. Patterns of Failure after Adjuvant Stereotactic Body Radiation Therapy in Patients with Pancreatic Cancer with Close or Positive Margins. Poster

San Antonio Breast Cancer Symposium, Dec 2020, San Antonio, Tx

• Richman AH, Patel AK, Soran A, Diego EJ, McAuliffe PF, Johnson RR, Brufsky A, Gorantla V, Steiman J, Lee JS, Beriwal S. Does genomic recurrence score predict for ipsilateral breast tumor recurrence after breast conservation therapy? Poster

2019 American College of Radiation Oncology, Orlando, Fl March 2019

• Ling DC, Iarrobino NA, Champ CE, Soran A, Beriwal S. Regional Recurrence Rates With or Without Complete Axillary Dissection for Breast Cancer Patients with Node-Positive Disease on Sentinel Lymph Node Biopsy after Neoadjuvant Chemotherapy. Poster

2019 Radiosurgery Society (RSS), San Diego, CA, March 2019

• Ling DC, Vargo JA, Gebhardt BJ, Grimm RJ, Clump DA, Ferris RL, Ohr JP, Heron DE. Dose-Response Modeling the Risk of Carotid Bleeding Events after Stereotactic Body Radiation Therapy for Previously-Irradiated Head and Neck Cancer. Oral Presentation

2019 American Radium Society (ARS), Dana Point, CA, April 6-9, 2019

• Ling DC, Iarrobino N, Champ CE, Soran A, Beriwal S. Regional recurrence rates with or without complete ancillary dissection for breast cancer patients with node-positive disease on sentinel lymph node biopsy after neoadjuvant chemotherapy. Oral presentation

Winner – James D. Cox Award of Scientific Merit – top scoring abstract of the Annual Meeting

2019 American Brachytherapy Society (ABS), Miami, Fl, June 13-15, 2019

• Rodriguez-Lopez JL, Ling DC, Kim H, Houser CJ, Beriwal S. Risk of Ureteral Stenosis after 3D MRI-Based Brachytherapy for Cervical Cancer. Oral Presentation
• Patel AK, Houser, CJ, Benoit R, Smith RP, Beriwal S. Patient-Reported Bowel Quality of Life with the Combination of Prostate External Beam Radiation, Brachytherapy Boost, and SpaceOAR. ePoster
• Ling DC, Vargo JA, Glaser SM, Kim H, Beriwal S. Outcomes after Definitive Re-irradiation with 3D Brachytherapy with or without External Beam Radiation Therapy for Vaginal Recurrence of Endometrial Cancer. Poster presentation
• Ling DC, Chen KS, Benoit RM, Beriwal S, Smith RP. Long-term Patient-Reported Rectal Bleeding and Bowel-Related Quality of Life Following Cs-131 Prostate Brachytherapy. Poster Presentation

62nd Annual ASTRO Meeting Chicago, Ill September 15-18, 2019

• Ling DC, Sutera P, Iarrobino N, Diego E, Soran A, Johnson R, Bhargava R, Champ C, Beriwal S. Is Multifocal Regression a Risk Factor for Ipsilateral Breast Tumor Recurrence in the Modern Era After Neoadjuvant Chemotherapy and Breast Conservation Therapy? Digital Poster
• Patel AK, Ling DC, Smith RP, Heron DE, Beriwal S. The Impact of Clinical Pathways on Adoption of Hypofractionated External Beam Radiation in Patients with Low or Intermediate-Risk Prostate Cancer. Poster
• Richman A, Ling DC, Vargo JA, Sukumvanich P, Berger J, Boisen M, Edwards R, Taylor S, Courtney-Brooks M, Olawaiye A, Orr, B, Beriwal S. Dose-Escalated Intensity Modulated Radiation Therapy in Patients with Locally Advanced Vulvar Cancer – Does it Increase Response Rate? Digital Poster
• Keller, A, Ling DC, Vargo JA, Sukumavanich P, Berger J, Boisen M, Edwards RP, Taylor SE, Courtney-Brooks M, Olawaiye A, Orr B, Beriwal S. Adjuvant Bone-marrow Sparing IMRT in Endometrial Cancer Patients Treated with Sequential Chemotherapy – Does it Help with Completion Rate? Digital Poster
• Rodriguez-Lopez, JR, Flickinger JC, Gerszten P, Amankulor N, Burton S, Olson A. Recursive Partitioning Analysis of Patients with Spine Metastases Treated with Stereotactic Body Radiotherapy. Digital Poster
• Patel AK, Olson A, Karlovits BJ, Beriwal S, Nguyen N. Impact of Fluciclovine PET/CT on Management of Patients with Biochemically Recurrent Prostate Cancer. Poster
• Iheagwara UK, Vargo JA, Boisen M, Taylor S, Berger J, Comerci J, Orr B, Sukumvanich P, Olawaiye A, Kelley J, Edwards R, Courtney-Brooks M, Beriwal S. Regional control and dose-response for chemoradiotherapy in locally-advanced endometrial cancer. Mini-oral
• Pifer, P.M., Martin, D.J, Bice, R., Renz, P., Beriwal, S., Vargo, J.A. Retrocrural Lymph Node Positivity on PET/CT Staging in Esophageal and Gastroesophageal Junction Cancer: Implications for Radiotherapy Clinical Target Volume Design. Poster

Frontier of Radiosurgery Milan, Italy October 24-25, 2019

• Ling DC, Kim H, Vargo JA, Beriwal S, Smith KL. Cost-Effectiveness Analysis of Upfront SBRT for Oligometastatic Stage IV Non-Small Cell Lung Cancer Based on Mutational Status. Oral presentation

San Antonio Breast Cancer Symposium, 2019

• Blohmer M, Zhu Li, Beriwal S, Rodriguez-Lopez J, Rosenzweig M, Tseng G, Lucas PC, Lee A, Oesterreich S, Jankowitz RC. Poster

2018 Multidisciplinary Head and Neck Cancer, Scottsdale, AZ, February 15-17, 2018

• Gebhardt BJ, Vargo JA, Ling DC, Jones B, Clump DA, Ohr JP, Ferris RL, Heron DE. Risk of severe laryngeal toxicity following re-irradiation with head and neck stereotactic body radiation therapy.

2018 American Society Brachytherapy, San Francisco, June 7-9, 2018

• Ling D, Smith RP, Heron DE, Beriwal S. Declining Brachytherapy Utilization for High-risk Prostate Cancer – Can Clinical Pathways Reverse the Trend? Oral presentation
• Gebhardt BJ, Balasubramanya R, Thomas J, Kelley J, Sukumvanich P, Edwards R, Comerci J, Olawaiye A, Courtney-Brooks M, Boisen M, Berger J, Beriwal S.Magnetic Resonance Imaging (MRI) Response in Patients Treated with Definitive Radiation Therapy for Medically Inoperable Endometrial Cancer – Does it Predict for Better Outcome? Oral Presentation
• Rodriguez-Lopez JL, Burton S, Weiss KR, McGough RL, Goodman MA, Beriwal S, Vargo JA, Olson AC. Adjuvant High Dose Rate Brachytherapy Combined with Vacuum-Assisted Closure for Soft Tissue Sarcomas: The University of Pittsburgh Medical Center Experience. Snap Oral (e-Poster)
• Horne ZD, Kalash R, Edwards RP, Kelley, JL, Comerci JT, Olawaiye AB, Courtney-Brooks M, Boisen MM, Berger JL, Sukumvanich P, Beriwal S. 3D MRI-Based Brachytherapy for Cervical Cancer: Can Dose Overcome Response. Snap Oral (e-Poster)
• Patel A, Houser C, Benoit R, Smith RP, Beriwal S. Evaluation of Dosimetric Parameters and Quality of Life Outcomes with Use of SpaceOAR in Patients Undergoing Prostate Seed Brachytherapy Boost after External Beam Radiation. Poster
• Kalash R, Horne ZD, Smith RP, Benoit R, Houser C, Beriwal S. Quality of Life Outcomes Following Prostate Brachytherapy in Patients With An Elevated Pre-Treatment AUA Score – How High is Too High? Poster
• Kalash R, Smith RP, Benoit R, Houser C, Beriwal S. Focal Brachytherapy Using Cesium-131 In Low-Risk Prostate Cancer. Poster

Travel Grant awarded to Diane Ling, MD.

61^th Annual ASTRO Meeting, San Antonio, TX October 21-24. 2018

• Ling DC, Beriwal S, Beichner D, Heron DE. Survival for patients with metastatic disease – How good are radiation oncologists at predicting survival? Posting viewing
• Gebhardt, BJ, Vargo JA, Kim H, Houser C, Glaser S, Sukumvanich P, Olawaiye A, Kelley J, Edwards R, Comerci J, Courtney-Brooks M, Beriwal S. Image-based multichannel vaginal cylinder brachytherapy for the Definitive Treatment of Vaginal cancers. Poster viewing
• Horne ZD, Dohopolski M, Pradhan D, Bhargava R, Edwards R, Kelley J, Comerci J, Olawaiya A, Courney-Brooks M, Boisen M, Berger J, Taylor S, Sukumvanich P, Beriwal S.Chemoradiation therapy for vulvar squamous cell carcinoma: Does p16-positivity influence locoregional control? Oral presentation
• Schuab M, Dohopolski M, Horne ZD, Burton S, Christie N, Jang SY, Heron DE. Lung stereotactic body radiation therapy: Is there a difference in outcome based on respiratory gating? Poster viewing
• Horne ZD, Karukonda P, Kalash R, Edwards R, Kelley J, Comerci J, Olawaiye A, Courtney-Brooks M, Boisen M, Berger J, Taylor S, Sukumvanich P, Beriwal S. Single-institution experience in 3D MRI-based brachytherapy for cervical cancer for 230 women: can dose overcome poor response? Poster Discussion
• Rodriguez-Lopez JL, Ling DC, Heron DE, Beriwal S. Using Clinical Pathways to Standardize Adoption of Hypofractionated Whole-breast Irradiation for Women Younger Than 50. Oral presentation
• Patel AK, Ling DC, Richman A, Champ C, Huq SM, Heron DE, Beriwal S. Hypofractionated Whole Breast Irradiation in Large-Breasted Women – Is There A Predictor for Acute Skin Toxicity? Poster Discussion
• Iheagwara UK, Holeva K, Bakkenist C, Shogan J, Engh J, Amankulor N, ClumpDA. Immuno-profile of a phase II clinical trial utilizing preoperative stereotactic radiosurgery followed by surgery in cancer patient with metastatic lesions in the brain. Poster viewing
• Kalash R, Horne ZD, Smith RP, Champ C, Appleman L, Beriwal S. Radium 223 for Men with pretreated metastatic castrate resistant prostate cancer, too little too late? Poster viewing
• Kalash R, Iarrobino N, Beriwal S, Sun M, Glaser S, Champ C. Palbociclib enhances pulmonary fibrosis in patient undergoing thoracic radiation therapy: A case series and review of the literature. Poster viewing.
• Iarrobino N, Kalash R, Gill B, Holeva K, D'Ambrosio D, Heron DE. Dosimetric correlates and patient-reported quality of life among prostate cancer patients treated with stereotactic body radiation therapy (SBRT). Poster viewing
• Dohopolski M, Horne ZD, Pradhan D, Bhargava R, Edwards R, Kelley J, Comerci J, Olawaiye A, Courtney-Brooks M, Boisen M, Berger J, Taylor S, Sukumvanich P. Beriwal S. Adjuvant radiation therapy for vulvar squamous cell carcinoma: does p16-positivity influence locoregional control? Poster
• Sutera P, Clump DA, Kalash R, D'Ambrosio D, Mihai A, Wang H, Petro D, Burton SA, Heron DE. Patient reported-quality of life in oligometastatic cancer treated with SBRT: Interim report of a phase II multicenter clinical trial. Oral Presentation
• Pifer, P.M, Bice, R., Jacobson, G., Lupinacci, K., Beriwal, S., Hazard, H., and Vargo, J.A. "The Lack of Consensus of International Contouring Guidelines for the Dorsal Border of the Chest Wall CTV: What is the Impact on Organs at Risk and Relationships to Patterns of Recurrence in the Modern-Era?" Poster

2018 Society for NeuroOncology, New Orleans, LA, November 15-18, 2018

• Keller A, Patel H, Nguyen S, All S, Pearson L, Ramakrishna NR. Distant brain failure following stereotactic radiosurgery for brain metastases from non-small cell lung cancer. Poster
• Keller A, Patel H, Nguyen S, All S, Pearson L, Ramakrishna NR, Distant Brain Failure Following Stereotactic Radiosurgery for Brain Metastases from Breast Cancer. Poster

2018 Best of ASTRO, San Francisco, CA, November 30-December 1, 2018

• Horne ZD, Dohopolski M, Pradhan D, Bhargava R, Edwards R, Kelley J, Comerci J, Olawaiya A, Courney-Brooks M, Boisen M, Berger J, Taylor S, Sukumvanich P, Beriwal S.Chemoradiation therapy for vulvar squamous cell carcinoma: Does p16-positivity influence locoregional control?

ASCO Gastrointestinal Cancers Symposium, San Francisco, CA, January 19-21, 2017

• Horne ZD, Sun W, Gibson MK, Pennathur A, Luketich JD, Karlovits BJ, Heron DE, Greenberger JS. Converting borderline-resectable, locally-advanced esophageal carcinoma to resectability with neoadjuvant chemoradiotherapy. Poster Presentation

2017 Annual American College of Radiation Oncology (ACRO) Meeting, Orlando, Fld March 9-11, 2017

• Horne ZD, Dohopolski MJ, Gabani P, Clump DA, Burton S, Heron DE. Thoracic reirradiation with SABR for residual/recurrent or new primary non-small cell lung cancers within a previously irradiated field: a single institution experience. Poster Presentation
• Glaser S, Dohopolski M, Balasubramani G, Flickinger J, Beriwal S. Glioblastoma (GBM) in the Elderly: Radiotherapy Fractionation with Concurrent Single Agent Chemotherapy. Poster Presentation
• Gebhardt BJ, Horne ZD, Moore A, Och M, Kim H, Lalonde R, Huq S, Heron DE, Beriwal S. Clinical Feasibility and Dosimetric Outcomes of Deep Inspirational Breath Hold Technique in Adjuvant Treatment of Left-Sided Breast Cancers Utilizing Visual Feedback Googles. Poster Presentation

Multidisciplinary Thoracic Cancers Symposium, San Francisco, CA, March 16-18, 2017

• Gebhardt BJ, Horne ZD, Heron DE, Beriwal S. Standardization of Radiation Therapy Dose for locally-advanced non-small cell lung cancer (NSCLC) through changes to a lung cancer clinical pathway in a large, integrated comprehensive CancerCenter Network. Oral Presentation
• Horne ZD, Richman A, Clump DA, Burton SA, Luketich J, Heron DE. Mediastinal/hilar stereotactic ablative radiotherapy for primary and oligorecurrent non-small cell lung cancer. Poster Presentation.

2017 American Brachytherapy Society (ABS) World Conference, Boston, MA April 20-22, 2017

• Prabhu A, Horne ZD, Glaser S, YouTube as a Source of Patient Information: Assessing Quality of Information in Brachytherapy Education Videos. Poster Presentation
• Horne ZD, Balasubramani GK, Sukumvanich P, Beriwal S. Social and Racial Divides in the Utilization of Brachytherapy for Common Malignancies. Oral Presentation
• Glaser S, Image Based Brachytherapy with MRI-Based Planning in the Treatment of Cervical Cancer: A Single Institution Outcome Analysis of 220 Patients. Oral Presentation
• Gebhardt BJ, Gill BS, Kim H, Houser C, Glaser SM, Kelley J, Sukumvanich P, Edwards R, Comerci J, Olawaiye A, Courtney-Brooks M, Boisen M, Berger J, Beriwal S. Image-Guided Brachytherapy for Definitive Treatment of Inoperable Endometrial Carcinoma. Oral Presentation
• Kalash R, Rangaswamy B, Glaser S, Kim H, Houser C, Beriwal S. The Use of Functional MRI in Cervical Cancer Patients with Incomplete Response on PET/CT Following MRI Guided High-Dose Rate Brachytherapy. Oral Presentation – Plenary. Judith Stitt Abstract Award for Best Abstract

ESTRO 36, Vienna, Austria May 5-9, 2017

• Gebhardt BJ, Horne ZD, Ahrendt GM, Diego E, Heron DE, Beriwal S. Standardization of Nodal Radiation Therapy (RT) through Changes to a Breast Cancer Clinical Pathway (CP) throughout a Large, Integrated Cancer Center Network in the United States. Poster Presentation
• Gebhardt BJ, Horne ZD, Ahrendt GM, Diego E, Beriwal S. Omission of completion axillary lymph node dissection in patients underrepresented in ACOSOG Z11 Trial E-poster presentation
• Horne ZD, Dohopolski M, He S, Gill BS, Beriwal S. Symptomatic pelvic insufficiency fracture in women after pelvic RT- is there a dosimetric correlate? Poster presentation

60th Annual ASTRO Meeting, San Diego, CA September 24-27, 2017

• Ling DC, Flickinger JC, Burton S, Heron DE, Ghassan B, Engh J, Gerszten P, Amankulor N, Vargo JA. Long-term Outcomes After Stereotactic Radiosurgery for Spine Metastases: Radiation Dose-Response for Late Toxicity. Oral Presentation
• Gebhardt BJ, Karukonda P, Heron DE, Beriwal S. Standardization of Radiation Therapy Dose for Locally-advanced Non-Small Cell Lung Cancer (NSCLC) through Changes to a Lung Cancer Clinical Pathway in Large Network. Poster
• Gebhardt BJ, Horne ZD, Dohopolski M, Kelley J, Sukumvanich P, Edwards R, Comerci J, Olawaiye A, Courney-Brooks M, Boisen M, Berger J, Beriwal S. Does adjuvant therapy make a difference for Stage 1A type 2 endometrial cancer? E-Poster
• Prabhu AV, Glaser SM, Horne ZD, Agarwal N, Heron DE, Beriwal S. Red Journal versus Green Journal: A Comparison of the Top 100 Most Influential Articles Published from 2006-2015. Poster
• Prabhu AV (student), Funahashi R, Gupta R, Badeti S, Adeeb N, Moore JM, Agarwal N, Heron DE, Quang TS, Beriwal S. A National WestLawNext Database Analysis of Malpractice Litigation in Radiation Oncology. Poster
• Horne ZD, Dohopolski M, Gebhardt BJ, Edwards R, Kelley J, Bomerci J, Olawaiya A, Courtney-Brooks M, Boisen M, Berger J, Sukumvanich P, Berwial S. Single-institutional outcomes of adjuvant brachytherapy alone for stage I endometrial cancer- are outcomes consistent with randomized studies? Poster
• Kalash R, Rangaswamy B, Glaser S, Berwal S. The Predictive Value of Pre-Treatment ADC in Cervical Cancer Patients treated with MRI Guided High-Dose Rate Brachytherapy – Ready for Prime Time? Poster

2017 RSS Annual Scientific Meeting, Las Vegas, NV, November 2-4, 2017

• Gebhardt BJ, Vargo JA, Ling DC, Clump DA, Ohr JP, Ferris RL, Heron DE. Carotid Dosimetry and The Risk of Carotid Blowout Syndrome (CBOS) following Re-irradiation with Head and Neck Stereotactic Body Radiation Therapy (SBRT). Oral Presentation
• Ling DC, Flickinger JC, Burton SA, Heron DE, Quinn AE, Bejjani GK, Engh JA, Gerszten PC, Amankulor NM, Vargo JA. Risk of Vertebral Compression Fractures in Long-term Survivors After Stereotactic Radiosurgery for Spine Metastases. Oral Presentation. Best Medical Resident Challenge
• Horne ZD, Dohopolski MJ, Clump DA, Burton S, Heron DE. Stereotactic body radiation therapy for the treatment of pulmonary oligometastases originating from non-lung primaries.

The ASTRO Head & Neck Cancer Symposium, Scottsdale, AZ. February 18-20, 2016

• Glaser S, Mandish S, Gill B, Balasubramani G, Beriwal S. Anaplastic Thyroid Cancer (ATC): Prognostic Factors, Patterns of Care, and Overall Survival
• Gill BS, Beriwal S, Duvvuri U, Balasubramani GK, Heron DE, Clump DA. External beam radiotherapy (EBRT) for pT4 differentiated thyroid carcinomas: A National Cancer Data Base (NCDB) analysis.
• Gebhardt BJ, Ohr J, Bauman JE, Ferris RL, Duvvuri, U, Kim S, Johnson JT, Heron DE, Clump DA. Primary salivary gland malignancies treated with adjuvant radiation therapy with or without concurrent chemotherapy: Prognostic Factors & Treatment Outcomes.

2016 Annual American College of Radiation Oncology (ACRO) Meeting, Orlando, FL. March 17-19, 2016

• Glaser SM, Stereotactic Body Radiotherapy (SBRT) for Non-operative Pancreatic Cancer – Patterns of Care and Overall Survival. Oral presentation
• Vargo JA. Underutilization of Radiotherapy in Early-Stage Marginal Zone Lymphoma. Oral presentation

ESTRO 25, Turin, Italy, April 29- May 3, 2016

• Glaser SM, Balasubramani GK, Beriwal S. Stage II testicular seminoma: patterns of care and survival by treatment strategy. Oral presentation.

2016 American Brachytherapy Society (ABS) World Conference, San Francisco, CA June 27-29, 2016

• Glaser SM, The Declining Use of Brachytherapy Boost for Prostate Cancer Despite Associated Survival Advantage. Oral Presentation.
• Glaser SM. Effect of Imaging Modality on Urethral Dosimetry in Patients Undergoing Gynecological Brachytherapy Snap Oral. (E-poster)
• Glaser SM, Long-Term Quality of Life in Prostate Cancer Patients Treated with Cesium-131. Snap Oral (E-poster)
• Gebhardt BJ. Clinical Outcomes with Definitive Treatment of Vaginal Cancer with Image-Based Multichannel Vaginal Cylinder Brachytherapy. Oral presentation
• Horne, ZD. Feasibility And Early Results With A Hybrid Intracavitary/interstitial Applicator For Locally Advanced Cervical Cancers With Poor Response To Chemoradiotherapy. Poster

2016 the Radiosurgery Society Scientific Meeting, Orlando, Fl, June 16-18, 2016

• Gogineni E, Vargo JA, Glaser SM, Flickinger JC, Burton SA, Engh JA, Amankulor NM, Beriwal S, Quinn AE, Ozhasoglu C, Heron DE. Long-term survivorship following stereotactic radiosurgery alone for brain metastases: risk of intracranial failure and implications for surveillance and counselling. Oral presentation at ASTRO 2016. Oral presentation and travel award winner at RSS 2016.

59th Annual ASTRO Meeting, Boston, MA September 25-28, 2016

• Horne ZD, Glaser S, Vargo JA, Ferris RL, Balasubramani G, Clump DA, Heron DE, Beriwal S. Confirmation of proposed human papillomavirus risk-adapted staging according to AJCC/UICC TNM criteria for positive oropharyngeal carcinomas. Oral Presentation
• Vargo JA, Ward M, Caudell J, Riaz N, Dunlap N, Isrow D, Zakem S, Dault J, Awan M, Higgins K, Beitler J, Yao M, Machtay M, Siddiqui F, Trotti A, Lee N, Koyfman S, Heron DE. Optimal Treatment Selection of SBRT and IMRT for Re-Irradiation of Head and Neck Cancer: A Multi-Institution Comparison. Oral Presentation
• Vargo JA, Balasubramani G, Beriwal S. Alarming Rates of Omission or Inadequate Radiotherapy in Extra-nodal Natural Killer T-cell Lymphoma Nasal Type in the United States. Poster presentation.
• Ling D, Vargo JA, Ferris RL, Ohr J, Clump DA, Yau W, Duvvuri U, Kim S, Johnson JT, Bauman JE, Branstetter B, Heron DE. Risk of Severe Toxicity Based on Site of Recurrence in Patients Treated with Stereotactic Body Radiation Therapy for Recurrent Head and Neck Cancer. Oral Presentation
• Garda A, Glaser S, Vargo JA, Gill BS, Huq MS, Heron DE, Beriwal S. Clinical Pathways – A Step to Further Improve Implementation of Quality Radiation Delivery for Breast Cancer. Oral Presentation
• Gill BS, Viswanathan A, Balasubramani G, Sukumvanich P, Beriwal S. Implication of Adjuvant Radiotherapy and Dose-Response Relationship for Margin-Positive Vulvar Squamous Cell Carcinoma. Oral Presentation
• Gebhardt BJ, Glaser S, Beriwal S, Balasubramani G, Ferris RL, Heron DE, Clump DA. Adjuvant radiation therapy (RT) with or without chemotherapy in resected high-risk salivary gland malignancies (SGM): A National Cancer Data Base (NCDB) analysis. Poster Presentation
• Gebhardt BJ, Beriwal S, Heron DE. Peer review process for implementation of clinical pathways (CP): Does it improve compliance? Oral Presentation
• Berhane H, Gill BS, Bernard M, Olawaiye A, Sukumvanich P, Kelley J, Beriwal S. Outcomes of stage II endometrial cancer: UPMC CancerCenter experience. Oral Presentation
• Bernard ME, Gogineni E, Quan K, Zeh HJ, Burton SB, Heron DE. Interim Results for Prospective Trial of Adjuvant Stereotactic Body Radiation Therapy for Resected Pancreatic Adenocarcinomas with Close or Positive Margins. Poster Presentation
• Bernard ME, Glaser SM, Gill BS, Beriwal S, Heron DE, Luketich JD, Friedland DM, Socinski MA, and Greenberger JS. Results of a Single Institution Experience with Dose Escalated Chemoradiation for Locally-Advanced Unresectable Non-Small Cell Lung Cancer. Poster presentation
• Caudell JJ, Ward MC, Koyfman SA, Riaz N, Dunlap NE, Isrow D, Zakem SJ, Awan MJ, Vargo JA, Heron DE, Higgins KA, Beitler JJ, Yao M, Machtay M, Trotti AM, Siddiqui F, Lee NY. Multi-Institution Analysis of IMRT-based Re-Irradiation for Head and Neck Cancer: Improved Risk-Benefit Profile in the Modern Era. Oral presentation
• Ward MC, Riaz N, Caudell JJ, Dunlap NE, Isrow D, Zakem SJ, Dault J, Awan MJ, Vargo JA, Heron DE, Higgins KA, Beitler JJ, Yao M, Machtay M, Siddiqui F, Trotti AM, Lee NY, Koyfman SA. Multi-Institution Analysis of IMRT-based Re-Irradiation for Head and Neck Cancer: Prognostic Factors and Recursive Partitioning Analysis for Overall Survival. Oral presentation.
• Awan MJ, Zakem SJ, Ward MC, Machtay M, Riaz N, Caudell JJ, Vargo JA, Dunlap NE, Isrow D, Dault J, Higgins KA, Beitler JJ, Siddiqui F, Trotti AM, Lee NY, Koyfman SA, Heron DE, Yao M. Re-irradiation Outcomes after Upfront Larynx Preservation or Total Laryngectomy: A Multi-institutional Analysis. Poster presentation
• Kauffmann G, Gunther JR, Braunstein SE, Hara W, Spektor A, Brower JV, Stahl JM, Rao YJ, Vargo JA, Ye JC, Fields EC, Thomas Jr CR, Du KL, Kruser TJ, Jimenez RB, Hirsch AE. Updated Analysis of a Multi-institutional Radiation Oncology Clerkship Curriculum: A Report from the Radiation Oncology Education Collaborative Study Group. Poster presentation.

92nd Annual Meeting of Western Section AUA, Kauai, HI, October 23-28, 2016

• Glaser, S, Bongiorni DR, Goundappa BA, Balasubramani K, Roberts MS, Jacobs BL, Beriwal S, Heron DE, Greenberger JS. Multimodality Evaluation of Global Healthcare Spending For Prostate Cancer Patients within an Integrated Delivery and Finance System (IDFS). Oral Presentation.

2016 Best of ASTRO, Fort Lauderdale, Fl. November 11-12, 2016

• Gill BS, Viswanathan A, Balasubramani G, Sukumvanich P, Beriwal S. Implication of Adjuvant Radiotherapy and Dose-Response Relationship for Margin-Positive Vulvar Squamous Cell Carcinoma. Oral Presentation
• Vargo JA, Ward M, Caudell J, Riaz N, Dunlap N, Isrow D, Zakem S, Dault J, Awan M, Higgins K, Beitler J, Yao M, Machtay M, Siddiqui F, Trotti A, Lee N, Koyfman S, Heron DE. Optimal Treatment Selection of SBRT and IMRT for Re-Irradiation of Head and Neck Cancer: A Multi-Institution Comparison. Oral Presentation
• Garda A, Glaser S, Vargo JA, Gill BS, Huq MS, Heron DE, Beriwal S. Clinical Pathways – A Step to Further Improve Implementation of Quality Radiation Delivery for Breast Cancer. Oral Presentation

2016 Annual Conference International Society of Geriatric Oncology (SIOG), Milan, Italy November 17-19, 2016

• Horne ZD, Balasubramani G, Clump DA, Ferris RL, Heron DE, Beriwal S. National Patterns of care and outcomes of oropharyngeal squamous cell carcinomas in patients over 70 in the United States. Oral Presentation

2016 International Association for the Study of Lung Cancer (IASLC) 17th World Conference on Lung Cancer. Vienna, Austria December 4-7, 2016.

• Horne ZD, Richman AH, Clump DA, Burton SA, Luketich JD, Heron DE. Mediastinal/ Hilar Stereotactic Ablative Radiotherapy for Oligiorecurrent Non-Small Cell Lung Cancer. Poster Presentation

2016 San Antonio Breast Cancer Symposium, San Antonio, TX December 6-10, 2016

• Horne ZD, Gebhardt BJ, Balasubramani G, Beriwal S. Utilization and outcomes of post-mastectomy radiotherapy in women with 1-3 positive axillary nodes following neoadjuvant chemotherapy: a multiply-imputed, propensity-adjusted National Cancer Database Analysis. Poster Presentation.
• Gebhardt, BJ, Horne ZD, Heron, DE, Beriwal S. Standardization of nodal radiation therapy (RT) through changes to a breast cancer clinical pathway (CP) in a large, integrated comprehensive cancer center network. Poster Presentation.

2015 Society of Gynecologic Oncology Annual Meeting, Chicago, Il March 28-31, 2015

• Gill BS, Hansen K, Sukumvanich P, Beriwal S. Patterns of practice and outcomes of definitive radiation therapy in early stage inoperable endometrial cancer. Accepted as a featured poster presentation.
• Boisen MM, Vargo JA, Beriwal S, Sukumvanich P, Olawaiye AB, Kelley JL, Edwards RP, Huang M, Courtney-Brooks MB, Comerci JT. Surgical Outcomes of Patients Undergoing Extrafascial Hysterectomy Following Neoadjuvant High-Dose Rate Brachytherapy for Locally Advanced Endometrial Cancer Clinically Extending to the Cervix or Parametria. Accepted as a poster presentation.

2015 American Brachytherapy Society (ABS) Annual Meeting, Orlando, FL April 9-11, 2015

• Vargo, JA, Boisen MM, Comerci JT, Kim H, Houser C, Sukumvanich P, Olawaiye A, Kelley JC, Edwards RP, Huang M, Courtney-Brooks M, Beriwal S. Neoadjuvant High-Dose-Rate Brachytherapy Followed By Extrafascial Hysterectomy for Locally Advanced Endometrial Cancer Clinically Extending to Cervix or Parametria. Accepted as oral presentation.
• Vargo, JA, Kim H, Houser C, Sukumvanich P, Olawaiye A, Kelley JL, Edwards RP, Comerci JT, Huang M, Courtney-Brooks M, Beriwal S. Image-Based Multichannel Vaginal Cylinder Brachytherapy for Vaginal Cancers. Accepted as a snap-oral session.
• Gill BS, Hansen KJ, Sukumvanich P, Beriwal S. Primary Radiation Therapy for Non-Surgically Managed Stage I Endometrial Cancer: Utilization and Impact of Brachytherapy. Accepted as oral presentation.
• Glaser, S. Kim, H. Beriwal, S. Multi-channel Vaginal Cylinder Brachytherapy: Impact Of Tumor Size And Location On Dose To Organs At Risk. Accepted as a poster presentation

97th Annual American Radium Society (ARS) Meeting, Kauai, HI, May 2-5, 2015

• Gill BS, Minkoff D, Kim H, Houser C, Beriwal S. Cervical cancer outcome prediction to high-dose rate brachytherapy using quantitative magnetic resonance imaging analysis of tumor response to external beam radiotherapy. Accepted as oral presentation. Travel grant awarded.
• Holt DE, Gill BS, Clump DA, Burton S, Flickinger JC, Engh J, Heron DE. Salvage stereotactic radiosurgery for locally recurrent brain metastases treated previously with stereotactic radiosurgery.Accepted as oral presentation.

2015 Annual American College of Radiation Oncology (ACRO) Meeting, Arlington, VA, May 14-16, 2015

• Holt DE, Gill BS, Clump DA, Burton SA, Flickinger JC, Engh JA, Amankulor NM, Heron DE. Stereotactic radiosurgery in the initial treatment of small brain metastases: local control and prognostic factors of diffuse distant brain failure- Submitted

13th International Conference on Malignant Lymphoma, Lugano, Switzerland, June 17-20, 2015

• Gill BS, Vargo JA, Balasubramani GK, Beriwal S. Management trends and outcomes for stage I-II mantle cell lymphoma using the National Cancer Data Base (NCDB): Ascertaining the ideal treatment paradigm. Accepted
• Vargo JA, Gill BS, Balasubramani GK, Beriwal S. Treatment Selection and Survival Outcomes in Early-Stage Diffuse Large B-Cell Lymphoma: Does Modern Chemotherapy Replace the Need for Radiotherapy. Oral presentation.

58th Annual ASTRO Meeting, San Antonio, TX October 2015

• Glaser S, Vargo JA, Balasubramani G, Beriwal S. Patterns of Care and Propensity Score Adjusted Survival in Stage I Testicular Seminoma. Accepted as oral presentation.
• Gebhardt B, Rajagopalan MS, Gill BS, Heron DE, Rakfal S, Flickinger JC, Beriwal S. The Impact of Dynamic Changes to a Bone Metastases Pathway in a Large Integrated National Cancer Institute Designated Comprehensive Cancer Center Network. Accepted as oral presentation.
• Vargo JA, Gill BS, Balasubramani G, Beriwal S. Early-Stage Low Grade Follicular Lymphoma: How Much Evidence Do We Need to Adopt Radiation Therapy as the Primary Treatment? Accepted as oral presentation
• Horne ZD, Clump DA, Burton S, Heron DE. An Update of Radiosurgical Outcome Disparities by Tumor Location for Early-Stage Non-Small Cell Lung Cancer. Accepted as poster
• Chapman BW, Rajagopalan MS, Heron DE, Flickinger JC, Beriwal S. Clinical Pathways: A Catalyst for the Adoption of Hypofractionation in Early-Stage Breast Cancer. Accepted as poster.
• Greenberger JS, Shinde A, Berhane BW, Dixon T, Franicola D, Li S, Kagan V, Parmar K, Guinan E, Epperly M. Mitochondrial Localization of GS-Nitroxide JP4-039 Delivered in Intraoral Emulsion Ameliorates Radiation Mucositis in Fanconi Anemia (FA) Fancd2-/- Mice. Accepted as a poster
• Bernard ME, Holt DE, Rhieu BH, Luketich, JD, Greenberger JS. Outcomes of Chemoradiation and Dosimetric Predictors of Survival for Stage IIIB Non-Small Cell Lung Cancer. Accepted as Poster Presentation
• Holt DE, Gill BS, Clump DA, Si Young J, Flickinger JC, Burton SB, Engh JA, Amankulor NM, Huq MS, Heron DE. Single-isocenter volumetric modulated arc radiosurgery for targeting multiple brain metastases: Clinical outcomes and treatment parameters. Accepted as Poster Presentation.
• He S, Gill BS, Heron DE, Kelley JL, Sukumvanich P, Olawaiye A, Edwards R, Comerci J, Beriwal S. Long-term outcomes using adjuvant pelvic intensity modulated radiation therapy (IMRT) for endometrial carcinoma. Accepted as poster presentation.
• Xu KM, Gill BS, Balasubramani GK, Sukumvanich P, Krivak T, Beriwal S. Impact of adjuvant radiation therapy and chemotherapy on stage I-II clear cell endometrial carcinoma: A National Cancer Data Base (NCDB) analysis. Accepted as Poster Presentation.
• Gill BS, Olsheski M, D’Ambrosio D, Clump DA, Wegner RE, Iyer R, Burton S, Holeva K, Heron DE. Hypofractionated stereotactic body radiation therapy for low and intermediate risk prostate cancer: A multi-institutional phase II analysis. Accepted as poster Presentation

Best of ASTRO, San Diego, CA. November 13-14, 2015

• Gebhardt B, Rajagopalan MS, Gill BS, Heron DE, Rakfal S, Flickinger JC, Beriwal S. The Impact of Dynamic Changes to a Bone Metastases Pathway in a Large Integrated National Cancer Institute Designated Comprehensive Cancer Center Network.
• Vargo JA, Gill BS, Balasubramani G, Beriwal S. Early-Stage Low Grade Follicular Lymphoma: How Much Evidence Do We Need to Adopt Radiation Therapy as the Primary Treatment?

20th Annual Meeting Society for Neuro-Oncology, San Antonio, TX. November, 2015

• Holt DE, Bernard ME, Quan K, Clump DA, Engh JA, Amankulor NM, Burton SA, Heron DE. Salvage Stereotactic Radiosurgery to recurrent Glioblastoma Multiforme with prior radiotherapy. Society for Neuro-Oncology 20th Annual Meeting 2015. Oral presentation.

2014 San Antonio Breast Cancer Symposium, San Antonio, TX December 9-13, 2014

• Rajagpoalan MS, Utilization of Hypofractionated Radiation Therapy for Early Stage Breast Cancer in women over 50 years of age – A National Cancer Data Base Analysis. Accepted as a poster discussion. Travel Grant Awarded.

Radiological Society of North America, Chicago, Ill, November 30-December 5, 2014

• Vargo JA, Heron DE, Ferris RL, Clump DA, Branstetter BF, Seynnaeve C, Ohr J, Johnson J. The Prognostic Value of First FDG PET/CT Response Following Re-Irradiation with Stereotactic Body Radiotherapy plus Cetuximab in Patients with Recurrent Previously-Irradiated Squamous Cell Carcinoma of the Head and Neck: Results from a Prospective Phase II Trial. Accepted as an oral presentation
• Vangara BS, Kabolizadeh P, Berhane H, Smith RP, Clump DA, Heron DE. Post-Operative Simultaneous Integrated Boost-Intensity Modulated Radiation Therapy in Head and Neck Cancer: Outcomes from a Single Institution Series. Accepted as an oral presentation

57th Annual ASTRO Meeting, San Francisco, CA, September 14-17, 2014

• Bernard M, Ling D, Rwigema JC, Zeh H, Heron DE, Burton S. Adjuvant Stereotactic Body Radiotherapy for Resected Pancreatic Adenocarcinoma with Close or Positive Margins Accepted as digital poster
• Gill BS, Beriwal S, Rajagopalan MS, Wang H, Hodges K, Greenberger J. Quantitative Evaluation of Radiation Oncologists’ Adaptability to Cost-Effective Treatment Programs Accepted as a poster
• Glaser SM, Binks JT, McCoy C, Lansberry R, Lalonde R, Duvvuri U, Ferris R, Heron DE, Clump DA. A Dosimetric Analysis of Adjuvant Radiation Therapy Following Transoral Robotic Surgery (TORS) for Oropharyngeal Cancer Compared to Definitve Chemoradiation (CRT). Accepted as a poster presentation.
• Rajagopalan MS, Flickinger JC, Heron DE, Sukumvanich P, Kelley JL, Ahrendt GM, Beriwal S. Utilization of Hypofractionated Radiation Therapy for Early Stage Breast Cancer in the Elderly Population – A National Cancer Data Base Analysis. Accepted as a poster presentation.
• Xu KM, Rajagopalan, MS, Kim H, Beriwal S. Extended Field Intensity-Modulated Radiation Therapy for Gynecologic Cancers: Is the Risk of Duodenal Toxicity High? Accepted as a poster
• Lin JF, Rajagopalan MS, Sukumvanich P, Krivak TC, Olawaiye AB, Kelley JL, Beriwal S. Impact of Adjuvant Chemotherapy with Radiation for Node-Positive Vulvar Cancer: A National Cancer Data Base (MCDB) study. Accepted as an oral presentation.
• Kim H, Rajagopalan MS, Beriwal S, Smith K. Cost-effectiveness Analysis of 3D Image-Guided Brachytherapy Compared to 2D Brachytherapy in the Treatment of Locally Advanced Cervical Cancer. Accepted as a poster presentation
• Ling DC, Vargo JA, Wegner RE, Flickinger JC, Burton SA, Engh J, Amankulor N, Quinn AE, Ozhasoglu C, Heron DE. Post-operative stereotactic radiosurgery to the resection cavity for large brain metastases. Accepted as a digital poster discussion
• Vargo JA, Ferris RL, Ohr J, Clump DA, Davis K, Johnson J, Gibson M, Branstettter BF, Heron DE. Re-irradiation With Stereotactic Body Radiotherapy Plus Cetuximab In Patients With Recurrent Previously-irradiated Squamous Cell Carcinoma Of The Head And Neck: A Prospective Phase II Trial. Accepted as oral presentation. Travel Grant Award Winner
• Rwigema JCM, Nguyen D, Heron DE, Chen AM, Lee P, Vargo JA, Low DA, Huq S, Steinberg ML, Kupelian P, Sheng K. 4 Noncoplanar Steretactic Body Radiation Therapy for Head and Neck Cancers – Improved Local Control and Late Toxicities. Accepted as poster presentation

50th Annual American Society Clinical Oncologists (ASCO) Meeting, Chicago, IL, May 30- June 3, 2014

• Kabolizadeh P, Rajagopalan, M. Patterns of Care for Omission of Radiation Therapy for Elderly Women with Early Stage Breast Cancer Receiving Hormonal Therapy. Accepted as poster discussion

96th Annual American Radium Society (ARS) Meeting, St. Thomas, US Virgin Islands, April 26-29, 2014

• Rajagopalan M, Flickinger JC, Heron DE, Beriwal S. Changing Practice Patterns for Breast Cancer Radiotherapy with Clinical Pathways: An Analysis of Hypofractionation in a Large, Integrated Cancer Center Network. Accepted as oral presentation with Travel award
• Vargo JA, Heron DE, Huq S. 4Pi Noncoplanar Stereotactic Body Radiation Therapy in Head and Neck Cancers. Accepted as a poster
• Kabolizadeh P, Berhane H. Simultaneous Integrated Boost-Intensity Modulated Radiation Treatment in Head and Neck Cancer: Outcomes From a Single Institution Series. Accepted as a poster discussion

American Brachytherapy Society (ABS) Annual Meeting, San Diego, CA April 3-5, 2014

• Gill BS, Kim H, Houser C, Olsen A. 3D Conformal Brachytherapy for Inoperable Endometrial Carcinoma: Discrepancies Between CTV EQD2 Values and Local Control. Accepted as oral presentation with a Travel Award
• Gill BS, Kim H, Houser C, Kelley J, Sukumvanich P, Edwards R, Comerci J, Olawaiye A, Huang M, Courtney-Brooks M, Beriwal S. Extended clinical outcomes for 3D high dose rate intracavitary brachytherapy with MRI-based planning for treatment of cervical cancer. Accepted as an oral presentation
• Vargo JA, Berhane H, Kim H, Houser C, Sukuvanich P, Olawaiya A, Edwards R, Kivak T, Comerci J, Beriwal S. Image-Based High-Dose-Rate Brachytherapy Salvage for Vaginal Recurrences of Endometrial Cancer: the Interplay of PORTEC 1 Risk Stratification. Accepted as a poster discussion
• Vargo JA, Kim H, Houser C, Beriwal S. Clinical Outcomes for 3-Dimensional High-Dose-Rate Vaginal Brachytherapy Using an Intravaginal Multichannel Cylinder: Improving Dosimetry to Decrease Toxicity for Primary and Recurrent Vaginal Cancers. Accepted as a poster discussion
• Rajagopalan MS, Beriwal S, Smith RP, Houser C, Benoit RM. Six-Year Biochemical Outcome in Patients Treated with Cs-131 Brachytherapy as Monotherapy for Prostate Cancer. Accepted as oral presentation
• Xu KM, Rajagopalan MS, Lin J, Sukumvanich P, Krivak TC, Beriwal S. Trends in the Utilization of Brachytherapy Boost in Vaginal Cancer in the United States. Accepted as Plenary Presentation

The ASTRO Head and Neck Symposium, Scottsdale, AZ, February 20-22, 2014

• Vargo JA, Ferris R, Clump DA, Heron DE. Stereotactic Body Radiotherapy + Cetuximab as Primary Treatment for Elderly Patients with Medically-Inoperable Head and Neck Cancer. Accepted as poster presentation

56th Annual ASTRO Meeting, Atlanta, GA, September 22-25, 2013

• Vargo, JA, Bhargava, R, Beriwal S. The Role of Radiation Therapy in Primary and Radiation Induced Angiosarcoma of the Breast: Impact on Patterns of Failure. Accepted as poster presentation
• Vargo JA, Ferris, R, Grandis, J, Duvvuri U, Johnson J, Ohr, J, Clump DA, Burton S, Heron DE. Post-operative Adjuvant Stereotactic Body Radiotherapy (SBRT) ± Cetuximab Following Salvage Surgery in Head and Neck Cancer. Accepted as poster presentation
• Kabolizadeh P, Beriwal S. Are RTOG Para-aortic Contouring Guidelines for Pancreatic Neoplasm Applicable to Other Malignancies – Assessment of Nodal Distribution in Gynecological Malignancies Accepted as oral presentation
• Gill BS, Beriwal S, Kim H, Houser, C. Clinical outcomes for 3D high dose rate intracavitary brachytherapy with MR-based planning for the treatment of cervical cancer. Accepted as oral presentation
• Rajagopalan MS, Clump, DA, Flickinger JC, Petro D, Burton S. Initial Report of a Prospective Phase II Study of Stereotactic Body Radiotherapy (SBRT) in Patient with Oligometastatic Disease. Accepted as poster presentation

18th Annual Society for Neuro-oncology Meeting, San Francisco, CA, November 22-24, 2013

• Gill BS, Peskorski DM, Lalonde R, Flickinger JC, Huq S. Hypofractionated re-irradiation of recurrent enhancing gliomas with 35 Gy: Can 20 Gy be delivered to surrounding T2 edema safely? Accepted as poster presentation

95th Annual American Radium Society (ARS) Meeting, Scottsdale, AZ, April 27-May 1, 2013

• Extent of peri-lesional edema differentiates radionecrosis from tumor recurrence following stereotactic radiosurgery for brain metastasis. Leeman JE, Heron DE, Clump DA, Flickinger JC, Mintz AH, Burton SA. Accepted as oral presentation
• David A. Clump, MD, PhD – Travel Grant Awarded

American Brachytherapy Society (ABS) Annual Meeting, New Orleans, LA, April 18-20, 2013

• Dosimetric comparison of Multi-channel vaginal cylinder High Dose Rate brachytherapy (HDR) to one single channel vaginal cylinder for patients with vaginal cancer. Kim H, Kim CH, Houser CJ, Vargo JA, Beriwal S.
• Feasibility of Diffusion Weighted Imaging in Assessing Tumor Response in Patients with Cervical Cancer Undergoing 3D MRI Guided High Dose-Rate Brachytherapy Kabolizadeh P, Rajagopalan MS, Kim H, Houser C, Hosseinzadeh K, Beriwal S. Oral presentation
• Peyman Kabolizadeh, MD, PhD – Travel Grant Awarded
• Five-Year Biochemical Outcome in Patients Treated with Cs-131 Brachytherapy as Monotherapy for Prostate Cancer. Rajagopalan MS, Beriwal S, Smith RP, Houser C, Benoit RM
• Three-Dimensional Image-Based High-Dose-Rate Brachytherapy Salvage for Recurrent Endometrial Cancer. Vargo JA, Beriwal S, Kim H, Houser C, Sukumvanich P, Olawayie A, Richards S, Kelley JC, Edwards RP, Krivak TC. Oral presentation
• Extended Outcomes Following Accelerated Partial Breast Irradiation using MammoSite Balloon-Based System. Verma V, Vargo JA, Heron DE, Kim H, Beriwal S.

Radiosurgery Society The SRS/SBRT Scientific Meeting, Carlsbad, CA, February 20-23, 2013

• Salvage Stereotactic Body Radiation Therapy (SBRT) for Medically-Inoperable Patients with NSCLC following RFA. Kabolizadeh P, Horne Z, Shah S, Clump DA, Vargo JA, Heron DE, Quinn A, Burton S, Abbas G, Schuchert MJ. Oral presentation
• Stereotactic Body Radiotherapy Salvage for Locally-Recurrent Central Non-Small-Cell Lung Cancers Vargo JA, Lehman J, Clump DA, Schuchert M, Christie N, Heron DE, Quinn A, Burton S. Oral presentation
• Stereotactic Body Radiotherapy for Recurrent Oropharyngeal Cancer – Influence of HPV and Smoking History Clump DA, Vargo JA, Rwigema JC, Davis K, Ferris R, Heron DE, Quinn A, Burton S. Oral presentation

23rd Annual Meeting American College of Radiation Oncology (ACRO), San Antonio, TX, February 14-16, 2013

• Dosimetric Definitions of Lung Volumes in Calculating Parameters for Radiation Induced Pneumonitis. Kabolizadeh P, Kalash R, Heron DE, Beriwal S.
• Salvage Stereotactic Body Radiotherapy for Local Failures after Sublobar Resection with I-125 Vicryl Mesh Brachytherapy. Gill BS, Clump DA, Vargo JA, Heron DE, Schuchert MJ, Christie NA, Burton SA.
• Stereotactic Body Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer: Location Matters. Horne ZD, Clump DA, Shah S, Vargo JA, Beriwal SD, Burton SA, Christie NA, Schuchert MJ, Landreneau RJ, Pennathur A, Luketich JD, Heron DE.

The Cancer Imaging and Radiation Therapy Symposium , Orlando, FL, February 8-9, 2013

• Horne ZD, Clump DA, Shah S, Vargo JA, Beriwal S, Burton SA, Chirstie NA, Schuchert MJ, Landreneau RJ, Pennathur A, Lukitch JD, Heron DE. Pretreatment SUVmax as a Marker for Progression-Free Survival in Stage I NSCLC following RFA. Oral presentation

10th GI ASCO Meeting, San Francisco, CA, Jan 24-27, 2013

• Radiosurgery vs Pancreaticoduodenectomy for Octogenarians with Pancreatic Cancer. Hogg ME, Kim CH, Boone BA, Lee KK, Moser AJ, Bartlett DL, Heron DE, Burton SA, Zeh HJ, Zureikat AH.

17th Annual Society for Neuro-oncology Meeting, Washington, DC, November 15-18, 2012

• T1/T2 match and high FLAIR lesion-to-edema ratio identify recurrence of brain metastases treated with stereotactic radiosurgery. Leeman JE, Clump DA, Flickinger JC, Burton SA, Mintz AH, Heron DE.

55th Annual ASTRO Meeting, Boston, MA, Oct 28-31, 2012

• Is there a secondary spike in urinary symptoms with Cs131 prostate brachytherapy? – A longitudinal analysis with patient reported EPIC survey and AUA score. Kim CH, Beriwal S, Benoit RM, Houser CJ, Smith RP.
• Incidence and predictors of acute and chronic rectal bleeding as reported by patients through EPIC questionnaire for prostate brachytherapy using Cesium. Kim CH, Beriwal S, Benoit RM, Houser CJ, Smith RP.
• Steroid prophylaxis prevents acute pain flare or swelling sensation following cervical spine stereotactic radiosurgery. Kim CH, Fu KY, Flickinger JC, Quader MA, Gerszten PC
• Stereotactic Body Radiotherapy in Treatment of Adenocarcinoma of Pancreas in Elderly Patients. Kim CH, Ling DC, Wegner RE, Heron DE, Zeh H, Moser AJ, Bahary N, Quinn A, Burton SA.
• Pathologic Response with Neoadjuvant Chemotherapy and Stereotactic Body Radiotherapy for Borderline Resectable and Locally-Advanced Pancreatic Cancer. Rajagopalan MS, Heron DE, Zeh HJ, Moser AJ, Krasinskas AM, Quinn AE, Burton SA.
• Treatment Duration > 2 Weeks Negatively Impacts Disease Control Following SBRT for Locally-Recurrent, Previously-Irradiated Head and Neck Cancers. Vargo JA, Heron DE, Ferris RL, Rwigema JCM, Wegner RE, Kalash R, Ohr J, Kubicek GJ, Burton S.
• The Impact of Treatment Volume and Duration on Toxicity Following SBRT for Locally-Recurrent, Previously Irradiated Head and Neck Cancer. Vargo JA, Heron DE, Ferris RL, Rwigema JCM, Wegner RE, Kalash R, Ohr J, Kubicek GJ, Burton S
• Fractionated Stereotactic Radiosurgery for Large brain metastases. Kabolizadeh P, Wegner RE, Rwigema JCM, Heron DE, Mintz AH, Burton S.
• Linear Accelerator Based Stereotactic Radiosurgery for the Treatment of Brainstem Metastases. Leeman JA, Clump DA, Wegner RA, Burton SA, Mintz AH, and DE Heron.

6th International Congress of the World Federation of Skull Base Societies and the 10th European Skull Base Society Congress 2012, Brighton, England May 16-19, 2012

• Stereotactic Radiosurgery for the treatment and palliation of base of skull metastases. Clump D, Wegner RE, Burton SA, Mintz, AH, and Heron DE Accepted Oral.

2012 World Congress of Brachytherapy (ABS), Barcelona, Spain May 10-12, 2012

• Urethral Dosimetry and Toxicity with High Dose-Rate Interstitial Brachytherapy. Rajagopalan MS, Kannan N, Kim H, Houser C, Beriwal S.
• Feasibility and Accuracy of T2 Signal Intensity Ratio and ADC Mapping in Assessment of Tumor Response for Patients Undergoing High Dose-Rate Brachytherapy for Cervical Cancer. Rajagopalan MS, Kim H, Houser C, Hosseinzadeh K, Beriwal S.
• Feasibility of ADC Mapping in Assessment of Tumor Response and residual disease for Patients Undergoing MRI based High Dose-Rate Brachytherapy for Cervical Cancer. Rajagopalan MS,Hosseinzadeh K, Beriwal S.

American Radium Society Conference (ARS), Las Vegas, NV April 28-May 2, 2012

• Dosimetric Parameters Predictive of Acute Gastrointestinal Toxicity in Patients with Anal Carcinoma Treated with Concurrent Chemotherapy and Intensity Modulated Radiation Therapy. Kabolizadeh P, DeFoe SG, Heron DE, Beriwal S. Accepted Oral
• Peyman Kabolizadeh, MD, PhD – Young Oncologist Essay Award
• Peyman Kabolizadeh, MD, PhD – Travel Grant Awarded
• Reirradiation of Brain Metastases from Small Cell Lung Cancer with Linear Accelerator Based Stereotactic Radiosurgery. Wegner RE, Rwigema JC, Mintz A, Burton S, Heron D.
• Recommendations for Post Mastectomy Radiation Therapy after Neoadjuvant Chemotherapy: An International Survey of Radiation Oncologists. Rajagopalan, MS Accepted Oral
• Malolan Rajagopalan, MD – Travel Grant Awarded

American College of Radiation Oncology (ACRO), Feb. 23-25 in Fort Myers, FL

• Prospective Evaluation of Patient-Reported Quality-of-Life Outcomes Following SBRT ± Cetuximab for Locally-Recurrent, Previously-Irradiated Head-and-Neck Cancer. Vargo JA, Heron DE, Ferris RL, Rwigema JCM, Wegner RE, Kalash R, Ohr J, Kubicek GJ, Burton S. Accepted Poster
• What is the right margin for target delineation in Stereotactic Body Radiation Therapy (SBRT) for previously-irradiated, recurrent squamous cell carcinoma of the head and neck. Wang K, Heron DE, Clump DA, Flickinger JC, Rwigema J-C, Ferris RL, Kubicek GJ, Ohr JP, Quinn AE, Ozhasoglu C, Branstetter BF. Accepted Oral Presentation with Poster

American Society for Radiology Oncology (ASTRO), Miami, FL October 2-6, 2011

• Analysis of metabolic patterns of recurrence on PET-CT for advanced head and neck cancer (HNC) patients treated definitively by IMRT: The Impact of using PET-CT for treatment planning and surveillance: preliminary results. Andrade RS, Kubicek GJ; Nelson AS; Nelson D; Heron DE. Accepted Poster
• Contouring inguinal and femoral nodes – How much margin is needed around the vessels? Kim C, Kim H, Beriwal S. Accepted Oral
• Dosimetric Analysis on Inter fractional Dose and Volume Change in Bladder and Rectum during Intensity Modulated Radiation Therapy for Gynecological Cancers with Daily Cone Beam CT guidance. Kim H, Beriwal S, Parikh S, Houser C. Accepted Poster
• Dosimetry and Early Clinical Outcomes of 3D Treatment Planning for High Dose Rate Brachytherapy of Medically Inoperable Endometrial Cancer. Olson AC, Beriwal S, Kim H, Houser C, Wegner R, Heron D, Richard S, Kelly J, Edwards R, Sukumvanich P, Zorn K, Krivak T, Olawaiye A. Accepted Poster
• Quality Assurance Analysis of a Large Multicenter Practice: Does Increased Complexity of Intensity Modulated Radiotherapy Lead to Increased Error Frequency? Olson AC, Wegner RE, Scicutella C, Heron DE, Greenberger JC, Huq S, Bednarz G, Flickinger JC. Accepted Poster
• Stereotactic Body Radiotherapy (SBRT) for Presacral Recurrence of Rectal Cancer. Kabolizadeh P, Rwigema J-C, DeFoe SG, Heron DE, Ozhasoglu C, Quinn A, Burton SA. Accepted Poster
• Stereotactic Body Radiotherapy (SBRT) for Recurrent and Early-Stage Centrally-Located Non-Small Cell Lung Cancer. Clump DA, Wegner RE, Heron DE, Burton SA, Christie NA, Schuchert MJ, Abbas G. Accepted Poster
• Stereotactic Radiosurgery to the Resection Cavity of Brain Metastases. Rwigema J-C, Wegner RE, Mintz AH, Burton SA, Heron DE.MD FACRO. Accepted Poster "Foreign Language Poster Walk with a Professor" program on Monday, October 3 from 10:45 p.m. to 12:15 p.m.
• The Effect of Treatment Time on Outcome in Nonsmall Cell Lung Cancer Brain Metastases treated with Stereotactic Radiosurgery. Kabolizadeh P, Wegner RE, Bernard M, Heron, Mintz AH, Burton SA. Accepted Poster

10TH Annual Congress International Stereotactic Radiosurgery Society (ISRS), Paris, France May 8-12, 2011

• Stereotactic radiosurgery for the treatment of melanoma brain metastases WEGNER Rodney*, REINEMAN Katharine, HERON Dwight, MINTZ Arlan, BURTON Steven Poster

American Association for Cancer Research, Orlando, FL April 2-6, 2011

• Fractionated Stereotactic Body Radiation Therapy as a Non-operative Salvage Strategy for Locally-Recurrent, Previously-Irradiated Non-Squamous Cell Cancers of the Head and Neck. Wegner RE, Vargo JA, Heron DE, Ferris RL, Burton S. Poster

American College of Radiation Oncology (ACRO), San Diego, CA February 24-26, 2011

• Fractionated SRS for large brain mets. Wegner RE, Rwigema JC, Heron DE, Mintz A, Burton S. Poster
• Reirradiation with Radiosurgery for Recurrent Glioblastoma Multiforme: A Single Institution's Retrospective Review. Wegner RE, Mintz AH, Heron DE, Burton SA. Poster
• Stereotactic Radiiosurgery for the Tretment of Brain Metastases from Non-small Cell Lung Cancer. Rwigema J-C, Wegner R, Bernard M, Heron DE, Mintz AH, Burton SA. Poster
• Fractionated Stereotactic Radiosurgery for the Treatment of Meningioma. Clump DA, Wegner RE, Bria C, Mintz AH, Heron DE, Burton SA. Poster

Radiological Society of North America (RSNA), Chicago, IL, November 29-December 3, 2010

• Evaluation of Treatment Outcome of the Patients with Anal Cancer Treated Using IMRT Technique: Radiobiological Study. Kehwar TS, Defoe GS, Beriwal S, Jones HA, Heron DE. Oral

Society for Neuro-Oncology, Montreal, Canada November 18-21, 2010

• Definitive chemo-radiotherapy and salvage fractionated radiosurgery resulting in extended survival in an elderly female with a GBM. D. A. Clump, R. E. Wegner, D. E. Heron, S. A. Burton, A.H. Mintz Poster
• The Src Activating Protein. AFAP is positioned to promote invasion in glioblastoma multiforme. Clump D, Engh J, Mintz A, Cunnick J, Flynn DC. Poster

International Conference on Radiation Biology, Chennai, India November 17-20, 2010

• Novel Mitochondrial Targeted Radiation Mitigators. Rajagopalan MS, Rwigema J-C, Gokhale A, Glowacki J, Frantz M-C. Wipf P, Doemling A, Beck B, Wang W, Li S, Gao X, Epperly MW, Greenberger JS. Oral

American Society for Radiology Oncology (ASTRO), San Diego, CA October 31-November 4, 2010

• Comparison of Whole versus Partial Vertebral Body Radiosurgery for Spinal Metastases: The Experience of a Single Institution. Patel VE, Wegner RE, Heron DE, Flickinger JC, Mintz AH, Burton SA, Gerszten P, Huq MS. Poster
• Dosimetric Parameters Are Predictive of Acute Gastrointestinal Toxicity in Patients Treated with Concurrent Chemotherapy and Intensity-Modulated Radiation Therapy for Anal Carcinoma. DeFoe SG, Kehwar TS, Beriwal S, Won S, Jones H, Heron DE. Oral
• PET/CT Based Intensity Modulated Radiation Therapy and Concurrent Chemoradiation Therapy for Anal Carcinoma – Preliminary Results. Andrade RA, Gillianne; G, Beriwal S, Heron DE. Oral
• Stereotactic Body Radiosurgery is a Safe and Efficacious Treatment Modality following RFA for Medically Inoperable NSCLC. Clump DA, Wegner RE, Heron DE, Abbas R, Schuchert MJ, Landreneau RJ, Luketich MJ, Burton SA. Poster
• Stereotactic Radiosurgery to the Resection Cavity of Brain Metastases . Rwigema J-C M, Wegner RE, Heron DE, Mintz AH. J. Novotny Jr., J.P. Bhatnagar, M.S. Huq Poster

2010 American Geriatrics Society Annual Scientific Meeting, Orlando, FL May 12-15, 2010

• Mitochondrial Targeting Nitroxide JP4,039 Ameliorates Irradiation-induced Delay in Bone Wound Healing in Mice and May Have Therapeutic Role for Acute Fractures in the Elderly. Rwigema J, Gokhale AS, Epperly M, Glowacki J, Wang H, Smith T, Patrene K, Wipf P, Greenberger JS. Poster

Pennsylvania Radiologic Society, Pittsburgh, PA May 8, 2010

• SRS for Patients with Brain Metastases from Small Cell Lung Cancer. Wegner RE, Olson A, Flickinger J, Kondziolka D, Lunsford D, Niranjan A. Oral

American Radium Society (ARS), Cancun, Mexico, May 1-5, 2010

• Outcome Analysis of Intensity Modulated Radiation Therapy and Concurrent Chemoradiation Therapy for Anal Carcinoma in a NCI Designated Integrated Cancer Center Network. DeFoe SG, Beriwal S, Jones H, Rakfal S, Heron DE, Smith R. Oral

American Brachytherapy Society (ABS), Atlanta, GA April 29-May 1, 2010

• 3D treatment planning for medically inoperable endometrial cancer: dosimetric analysis and early clinical outcomes. Olson AC, Beriwal S, Kim H, Houser C, Wegner RE, Heron DE, Richard SD, Kelly JL, Edwards RP, Sukumvanich P, Zorn KK, Krivak TK, Olawaiye AB. Oral

American Association for Cancer Research (AACR), Washington, DC April 17-21, 2010

• Mitochondrial Targeted Nitroxide JP4-039 Ameliorates Irradiation-induced Delay in Bone Wound Healing and Inhibits Orthotopic Tumor Growth. Rwigema JC, Gokhale AS, Epperly M, Glowacki J, Dixon T, Patrene K, Roodman GD, Wipf P, Greenberger JS. Poster
• Esophageal Administration of Manganese Superoxide Dismutate Plasmid Liposomes (MnSOD-PL) Reverses Thoracic Irradiation Sensitivity of Nitric Oxide Synthase One Homologous Recombinant Negative (NOS1 -/-) Mouse. Rajagopalan MS, Rwigema J-C, Stone B, Epperly MW, Goff J, Dixon T, Franciola D, Greenberger JS. Poster
• Manganese Superoxide Dismutase Plasmid/Lipid Complex (MnSOD-PL) and Manganese Superoxide Dismutase Plasmid/Liposome Complex (MnSOD-PL) Ameliorates Irradiation-Induced Delay in Bone Wound Healing. Rwigema J-C, Gokhale AS, Epperly M, Glowacki J, Dixon T, Patrene K, Roodman GD, Wipf P, Greenberger JS. Poster

American College of Radiation Oncology (ACRO), Lake Buena Vista, FL February 25-27, 2010

• Staged Stereotactic Irradiation for Treatment of Glomus Jugulare Tumors. Wegner RE, Rodriguez K, Heron DE, Burton S, Ferris R, Hirsch B. Poster
• Stereotactic Body Radiotherapy for the Treatment of Adrenal Metastases: A Retrospective Review. Torok JA, Wegner RE, Burton SA and Heron DE. Poster

Radiological Society of North America (RSNA), Chicago, IL, November 29-December 4, 2009

• A Quality Assurance Analysis of Reported Events for a Single Institution's Radiation Oncology Department. Olson AC, Wegner RE, Scicutella C, Heron DE, Bednarz G, Huq MS, Flickinger JC. Poster – Travel Grant Award

American Society for Radiology Oncology (ASTRO), Chicago, IL November 1-5, 2009

• Potentially Lethal Damage Repair is Enhanced by the Mitochondrial Targeted Nitroxide JP4-039. Rajagopalan MS, Gupta K, Epperly MW, Franicola D, Zhang X, Wang H, Zhar H, Vladimir AT, Kagan VE, Wipf P, Kanal A, Greenberger JS. Poster
• Stereotactic Body Radiotherapy (SBRT) in the Treatment of Locally-advanced, Recurrent and Unresectable Pancreatic Cancer. Rwigema JSM, Parikh SD, Burton SA, Quinn AE, Bahary N, Moser AJ, Zeh HJ, Lembersky B, Howell M, Heron DE. Poster
• What do Patients Want from Their Radiation Oncologist? Final Results from a Prospective Randomized Trial. Bhatnagar A, Land SR, Luong TM, Heron DE, Flickinger JC. Oral
• Locoregional Failure Patterns for Advanced Head and Neck Cancer (HNC) Treated Definitively by IMRT: The Impact of PET-CT on Treatment Planning. Andrade RS, Heron DE, Jain S, McCoy C. Poster
• Neo-adjuvant Chemotherapy versus Neo-adjuvant Chemoradiation Therapy followed by Esophagectomy versus Definitive Chemoradiation Therapy in Management of Locally-advanced Esophageal Carcinoma: A Single Institution Experience. DeFoe SG, Pennathur A, Flickinger JC, Heron DE, Gibson MK, Luketich JD, Greenberger JS. Poster
• Re-irradiation with Radiosurgery for Recurrent Glioblastoma Multiforme: A Single Institution’s Retrospective Review. Wegner RE, Mintz AH, Heron DE, Bejjani GK, Burton SA Poster.

Radiation Research, Savannah, GA October 4-7, 2009

• Irradiation inhibits human bone marrow stromal cell differentiation to osteoblasts in vitro. Gokhale AS, Epperly M, Glowacki J, Greenberger J. Poster
• Thoracic Irradiation in Nitric Oxide Synthase 1 Negative (NOSI-/-) Mice Induces Esophageal Dilation and Early Death While Their Mesenchymal Stem Cells Are Paradoxically Radioresistant. Zhang X, Rajagopalan M, Buchholz BM, Epperly MW, Bauer AJ, Franicola D, Dixon T, Cao S, Greenberger JS. Poster
• Thoracic Irradiation of Mice Induces Loss of Clara Cell Secretory Protein Expressing Lung Progenitor Cells. Rajagopalan MS, Epperly MW, Stripp RB, Reynolds SD, Shen H, Dixon T, Franicola D, Zhang X, Niu Y, Greenberger JS. Poster

American Association of Physicists in Medicine (AAPM), Anaheim, CA July 26-30, 2009

• Comparison of the End of Exhalation (EE) 4DCT Phase and Breadth-hold Scans. Michalski D, Andrade R, Heron DE, Huq MS. General Poster Discussion
• Model-based Esophageal Motion and Margin Determination. Michalski D, Andrade R, Mutaf YD, Heron DE, Huq MS. General Poster Discussion

American Geriatrics Society (AGS), Chicago, IL May 2009

• Radiosensitivity of Nitric Oxide Synthaese 1 Knockout Mice is Accompanied by Paradoxical Radioresistance of Mesenchymal Stem Cells in vivo. Rajagopalan MS, Epperly MW, Franicola D, Dixon T, Cao S, Studenski SA, Greenberger JS. Poster

American Brachytherapy Society (ABS), Toronto, ONT May 31-June 2, 2009

• Clinical and Dosimetric Variables Associated with Acute Bowel Toxicity Following Prostate Seed Brachytherapy with Cesium-131. Gokhale A, Beriwal S, Smith R, Benoit R, Li X. Poster
• Definitive Radiation Therapy for Endometrial Cancer in Medically-inoperable Elderly Patients. Wegner RE, Heron DE, Kim H, Mogus R, Beriwal S. Poster

12th Annual Meeting of the American Society of Gene Therapy, San Diego, CA May 27-30, 2009

• Intravenous MnSOD-PL Administration Ameliorates Ionizing Irradiation Induced Delay in Osseous Wound Healing. Gokhale AS, Epperly M, Glowacki J, Smith T, Patrene K, Roodman GD, Greenberger JS. Poster

American Association for Cancer Research (AACR), Denver, CO April 18-22, 2009

• The Mitochondrial Targeted Nitroxide JP4-039 Augments Potentially Lethal Irradiation Damage Repair. Rajagopalan MS, Gupta K, Epperly MW, Franicola D, Zhang X, Wang H, Kagan VE, Wipf P, Greenberger JS. Poster
• Thoracic Radiosensitivity of Homozygous Deletion Recombinant Negative Nitric Oxide Synthase 1. Rajagopalan MS, Epperly MW, Franicola D, Dixon T, Cao S, Greenberger JS. Poster

American Society for Therapeutic Radiology and Oncology (ASTRO), Boston, MA September 21-25, 2008

• Is There Decreased Duration of Acute Urinary and Bowel Symptoms Ater Prostate Brachytherapy with Cesium 131 Radioisotope? Defoe G, Beriwal S, Smith RP, Benoit R. Poster
• Clinical and Dosimetric Factors Associated with a Long Term Feeding Tube Requirement Following Chemoradiotherapy for Head and Neck Cancers. Gokhale AS, McLaughlin BT, Beriwal S, Flickinger JC, Smith RP, Heron DE, Ferris R, Argiris E, Gibson M. Poster Discussion
• Outcomes Comparison of IMRT vs. 3D Conformal Therapy of the Breast. Haley M, Greenberger J, Heron DE, Jones H, Lin C. Poster
• Treatment of Positive Surgical Margins Following Resection of Pancreatic Cancer with Stereotactic Radiosurgery. Parikh SD, Burton SA, Heron DE, Zeh HJ, Moser AJ, Bahary N, Lembersky BC, Ozhasoglu C, Quinn A. Poster
• Metabolic and Anatomic Tumor Volume Measurements Using Four-Dimensional (4D) PET-CT for Mobile Tumors in the Thorax and Abdomen. Narla VV, Andrade RS, Heron DE. Poster

Society of Nuclear Medicine (SNM), New Orleans, LA, June 14-18, 2008

• F-18 FDG PET Findings in Patients Undergoing Stereotactic Body Radiotherapy (SBRT) for Recurrent Squamous Cell Carcinoma of the Head and Neck (SCCHN). Mountz JM, Muthukrishnan A, Bencherif B, Lai S, Grandis J, Andrade RS, Heron DE. Poster

American Radium Society (ARS), Laguna Niguel, CA May 3-7, 2008

• Metabolic Volume Histograms and Voxel Map Response: SUV-Based Treatment Response Assessment Methods Using PET-CT. Fox T, Heron DE, Andrade R, Waller A, Crocker I. Poster
• The Impact of PET/CT on Squamous Cell Carcinoma of the Head and Neck (SCCHN) with IMRT. Andrade RS, Heron DE, Bhatnagar AJ, Wang Y, Ferris R, Johnson J, Branstetter B. Poster Presentation

American Society of Therapeutic Radiation Oncology (ASTRO), Los Angeles, CA October 28-November 1, 2007

• Fractionated Stereotactic Radiosurgery in the Management of Primary, Recurrent, and Metastatic Lung Lesions: The Role of PET/CT in Pre- and Post-treatment Disease Assessment. Gokhale AS, Heron DE, Burton S, Quinn A, Berlin R, Christie N. Poster Discussion
• Four-Dimensional Computed Tomography (4D-CT)-based Analysis of Intrafractional Esophageal Motion. Michalski D, Andrade RS, Huq S, Heron DE. Poster
• Outcomes Analysis of IMRT for Treatment of Head and Neck Cancers in a large Integrated Cancer Network. Bhatnagar AK, Heron DE, Beriwal S, Smith R, Andrade RS, MS Huq, Rakfal S, Bhari S, Johnson J, Ferris R Wang Y. Poster
• Analysis of Quality of Life Data in Head and Neck Cancer Patients Treated with IMRT. O’Neil M, Heron DE, Andrade RS, Flickinger J. Poster
• Accelerated Partial Breast Irradiation (APBI) with MammoSite^® An Interim Outcome Analysis with Two Years Follow-up. Haley M, Beriwal S, Heron D, Flak J, Kim H, Mogus R, Johnson R. Poster
• Impact of Chemotherapy (CT) on Parotid Dose-Volume Tolerance in Patients Treated with Intensity-Modulated Radiation Therapy for Head & Neck Cancers (HNC). Parikh SD, Heron DH, Bhatnagar AK, Burton S, Beriwal S, Huq S, Yang Y, Ferris RL, Argiris AE. Poster

92nd Annual Pennsylvania Radiological Society, Pittsburgh, PA October 12-14, 2007

• Stereotactic Radiosurgery for the Treatment of Pancreatic Cancer. Howell MC, Heron DE, Andrade R, Burton S. Oral

Congress of Neurological Surgeons 2008, San Diego, CA September 20, 2007

• A Matched-Pair Cost Effective Analysis Comparing Patients with Previously Untreated Spinal Metastases Treated with Stereotactic Radiosurgery vs. Conventional External Beam Radiotherapy. Atteberry DS, Haley M, Gerszten PC, Chang YF, Burton S, Heron DE. Discussion and Digital Poster

AAPM Minneapolis, MN July 22-26, 2007

• 4DCT-Based Study of Tumor and Lung Kinematics During Respiratory Cycle. Michalski D, Andrade R, Huq MS, Heron D. General Poster Discussion

International Stereotactic Radiosurgery Society, San Francisco, CA June 22-27, 2007

• The Value of Positron Emission Tomography and Computed Tomography (PET/CT) for Stereotactic Radiosurgery (SRS) re-Irradiation of Head and Neck Cancers in Treatment Planning and Response Assessment-Preliminary Results. de Andrade RS, Heron DE, Burton SA, Bhatnagar AK, Huq MS. Oral

American Society of Clinical Oncology (ASCO), Chicago, IL June 1-5, 2007

• Phase III Randomized Trial of Postoperative Radiotherapy (RT) with or without Carboplatin (Cb) in Patients (pts) with Head and Neck Squamous Cell Carcinoma (HNSCC). Johnson J, Agarwala S, Karamouzis MV, Heron DE, Eibling D, Cano E, Urba S, Gluckman J, Wang Y, Argiris A. Poster
• Long-term Outcomes with Concurrent Carboplatin, Paclitaxel, and Radiation Therapy in Locally Advanced, Inoperable Head and Neck Cancer. Ferris R, Agarwala S, Cano E, Heron DE, Johnson J, Myers E, Sandulache V, Bahri S, Wang Y, Argiris A. Poster Discussion.

17th Annual ACRO, San Diego, CA February 22-24, 2007

• Tangential Beam Intensity Modulated Radiation Therapy (IMRT) for Women with Large Size Breast – Dosimetric and Acute Toxicity Study. Beriwal S, Bhatnagar A, Heron DE, Flickinger J, Smith R, Deutsch M, Lalonde R, Huq S, Sontag M, Shogan J. Poster
• What do Patients Expect from Their Radiation Oncologist? Initial Results of Prospective Trial. Bhatnagar AK, Rodgers E, Land S, Heron DE, Flickinger J. Poster

6th Annual CyberKnife Users' Meeting, Palm Springs, CA January 24-28, 2007

• Stereotactic Radiotherapy for Head and Neck Tumors. Bhatnagar AK, Heron DE, Burton S, Ferris R, Ozhasglu C, Huq MD. Oral and Power Point
• The Value of Positron Emission Tomography and Computed Tomography (PET/CT) for Stereotactic Radiosurgery (SRS) Re-irradiation of Head and Neck Cancers in Treatment Planning and Response Assessment – Preliminary Results. de Andrade RS, Heron DE, Burton SA, Bhatnagar AK, Huq MS. Oral and Power Point

92nd Annual RSNA, Chicago, IL November 26-December 1, 2006

• Higher Toxicity Exists in Patients Treated with Combined External Beam Radiation Plus Brachytherapy Compared to External Beam Radiation Alone. RP Smith, AK Bhatnagar, S Beriwal, JF Flickinger, M Deutsch, S Huq, R Lalonde, DE Heron

29th Annual San Antonio Breast Cancer Symposium, San Antonio, TX December 14-17, 2006

• Initial Clinical Outcomes Analysis of Large Multi-Center Integrated Cancer Network for Implementation of Intensity Modulated Radiation Therapy for Breast Cancer. Bhatnagar AK, Beriwal S, Flickinger J, Deutsch M, Huq MS, Sontag M, Shogan J, Heron DE. Poster

RO, Philadelphia, PA November 5-9, 2006

• Dosimetric and Toxicities Comparison Between Prone and Supine Position IMRT for Endometrial Cancer. S Beriwal, SK Jain, DE Heron, RS de Andrade, CJ Lin, H Kim. Oral
• A Comparison of Supine Intensity-Modulated Radiotherapy Treatment with Prone 3D Conformal Radiotherapy for Rectal Cancer: Preliminary Results of Dosimetric Analysis. I Usiene, RP Smith, RS Andrade, DE Heron, C McCoy, M Mohney. Poster
• HER2/neu Status Doesn't Effect Patient Survival Following Stereotactic Radiosurgery for Brain Metastases from Breast Cancer. C Nelson, J Flickinger, AK Bhatnagar, D Kondziolka, A Brufsky, M Rosenzweig, LD Lunsford. Poster
• Initial Outcomes Results for Large Multi-Center Integrated Cancer Network for Treatment of Prostate Cancer with IMRT. AK Bhatnagar, DE Heron, S Beriwal, JC Flickinger, RP Smith, M Deutsch, Y Wang, MS Huq, R Lalonde, J Shogan. Oral Presentation Travel Grant

ESTRO, European Society for Therapeutic Radiology and Oncology, Leipzig, Germany October 8-12, 2006

• Re-irradiation with Stereotactic Radiosurgery in Patients with Head and Neck Tumors using Hybrid FDG-PET/CT to Improve Target Localization – Preliminary Results. Andrade R, Heron DE, Voynov G, Burton S, Ferris R, Grandis J, Avril N. Poster
• Stereotactic Radiotherapy for Head and Neck Tumors. Bhatnagar AK, Heron DE, Burton S, Ferris R, Ozhasglu C, Huq MS. Poster